<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="pmc-domain-id">3416</journal-id><journal-id journal-id-type="pmc-domain">molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430362</article-id><article-id pub-id-type="pmcid-ver">PMC12430362.1</article-id><article-id pub-id-type="pmcaid">12430362</article-id><article-id pub-id-type="pmcaiid">12430362</article-id><article-id pub-id-type="doi">10.3390/molecules30173516</article-id><article-id pub-id-type="publisher-id">molecules-30-03516</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Comparative Study of Ni(II) Complexes with Dithiocarbazate- and Thiosemicarbazone-Based Ligands: Synthesis, Crystal Structures, and Anticancer Activity</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0000-9145-008X</contrib-id><name name-style="western"><surname>Pessoa</surname><given-names initials="GS">Gabriel S.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Viana</surname><given-names initials="MP">Mariana P.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Oliveira</surname><given-names initials="KM">Katia M.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gatto</surname><given-names initials="CC">Claudia C.</given-names></name><xref rid="c1-molecules-30-03516" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Morzyk-Ociepa</surname><given-names initials="B">Barbara</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-30-03516">Laboratory of Inorganic Synthesis and Crystallography, Institute of Chemistry, University of Brasilia, Bras&#237;lia 70904-970, DF, Brazil</aff><author-notes><corresp id="c1-molecules-30-03516"><label>*</label>Correspondence: <email>ccgatto@unb.br</email></corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>30</volume><issue>17</issue><issue-id pub-id-type="pmc-issue-id">496502</issue-id><elocation-id>3516</elocation-id><history><date date-type="received"><day>31</day><month>7</month><year>2025</year></date><date date-type="rev-recd"><day>22</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>23</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>28</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 11:25:14.803"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="molecules-30-03516.pdf"/><abstract><p>The present work reports a comparative study of thiosemicarbazone (H<sub>2</sub>L<sup>1</sup>) and dithiocarbazate (H<sub>2</sub>L<sup>2</sup>) ligands and their Ni(II) complexes; [Ni(L<sup>1</sup>)(PPh<sub>3</sub>)] (<bold>1</bold>); [Ni(L<sup>1</sup>)(Py)] (<bold>2</bold>); [Ni(L<sup>2</sup>)(PPh<sub>3</sub>)] (<bold>3</bold>); and [Ni(L<sup>2</sup>)(Py)] (<bold>4</bold>). All compounds were characterized by spectroscopy analysis; and the complexes were also characterized by single-crystal X-ray diffraction. The crystal structures of the complexes revealed a distorted square planar geometry with the Ni(II) atoms coordinated to a double-deprotonated and tridentate ligand molecule by the <italic toggle="yes">ONS</italic> donor system. The coordination sphere is completed by the incorporation of pyridine or triphenylphosphine coligands at the metal center. Biological assays were conducted against the cell lines breast cancer (MCF-7); cisplatin-resistant ovarian cancer (A2780cis); lung cancer (A549); and nontumoral lung (MRC-5). The results show that cytotoxicity was significantly enhanced upon complexation for complexes (<bold>2</bold>) and (<bold>4</bold>); whereas it was suppressed for complexes (<bold>1</bold>) and (<bold>3</bold>) against the A2780cis and A549 cell lines. Notably; complex (<bold>2</bold>) exhibited superior cytotoxicity compared to cisplatin against both MCF-7 and A2780cis.</p></abstract><kwd-group><kwd>Ni(II) complexes</kwd><kwd>dithiocarbazate</kwd><kwd>thiosemicarbazone</kwd><kwd>crystal structures</kwd><kwd>Hirshfeld surface</kwd><kwd>anticancer activity</kwd></kwd-group><funding-group><award-group><funding-source>FAPDF</funding-source><award-id>00193-00001849/2023-49</award-id><award-id>00193-00000837/2024-88</award-id></award-group><award-group><funding-source>CNPq</funding-source><award-id>305038/2022-2</award-id></award-group><award-group><funding-source>CAPES</funding-source></award-group><award-group><funding-source>UnB</funding-source></award-group><funding-statement>This work was supported by FAPDF (process: 00193-00001849/2023-49 and 00193-00000837/2024-88), CNPq (PQ process: 305038/2022-2), CAPES, and UnB. The authors thank the funding foundations FAPDF, CNPq, CAPES, FINEP, and UnB for providing the equipment, reagents, and scholarships.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-30-03516"><title>1. Introduction</title><p>An ideal drug should treat a disease without causing undesirable side effects, be easy to use, and be affordable. However, many of the available drugs, especially those used to treat cancer, often cause significant discomfort during administration and may have adverse side effects [<xref rid="B1-molecules-30-03516" ref-type="bibr">1</xref>,<xref rid="B2-molecules-30-03516" ref-type="bibr">2</xref>]. This reality highlights the importance of increasing efforts to develop new drugs and therapeutic alternatives.</p><p>In recent decades, Schiff bases have attracted great attention due to their wide range of potential applications in various fields, such as catalysis, chemical sensors, and therapeutic agents [<xref rid="B3-molecules-30-03516" ref-type="bibr">3</xref>,<xref rid="B4-molecules-30-03516" ref-type="bibr">4</xref>]. Metal complexes with Schiff bases have demonstrated significant biological activity, including anticancer, antibacterial, and antifungal properties [<xref rid="B5-molecules-30-03516" ref-type="bibr">5</xref>,<xref rid="B6-molecules-30-03516" ref-type="bibr">6</xref>,<xref rid="B7-molecules-30-03516" ref-type="bibr">7</xref>]. Among the known Schiff bases, thiosemicarbazones and dithiocarbazates stand out, which are characterized by their imine or azomethine functional group, with significant pharmacological and structural properties (<xref rid="molecules-30-03516-f001" ref-type="fig">Figure 1</xref>).</p><p>Several compounds of the thiosemicarbazone class have shown significant antitumor activity, being capable of inhibiting the growth of cancer cells [<xref rid="B8-molecules-30-03516" ref-type="bibr">8</xref>]. Recent work demonstrates that thiosemicarbazones can coordinate with essential metal ions, such as copper and iron, disrupting tumor cell metabolism [<xref rid="B9-molecules-30-03516" ref-type="bibr">9</xref>,<xref rid="B10-molecules-30-03516" ref-type="bibr">10</xref>]. In addition, some thiosemicarbazones exhibit antibacterial and antiviral properties, further expanding their therapeutic potential [<xref rid="B11-molecules-30-03516" ref-type="bibr">11</xref>].</p><p>Dithiocarbazates have been widely studied due to their structural versatility and physicochemical properties, producing metal complexes with diverse geometries and biological activities [<xref rid="B12-molecules-30-03516" ref-type="bibr">12</xref>,<xref rid="B13-molecules-30-03516" ref-type="bibr">13</xref>,<xref rid="B14-molecules-30-03516" ref-type="bibr">14</xref>,<xref rid="B15-molecules-30-03516" ref-type="bibr">15</xref>]. A variety of complexes with different metals have been described in the literature, demonstrating that the pharmacological activity of free dithiocarbazates increased after complexation against several strains of cancer cells and pathogenic microorganisms, including bacteria and fungi [<xref rid="B13-molecules-30-03516" ref-type="bibr">13</xref>,<xref rid="B14-molecules-30-03516" ref-type="bibr">14</xref>,<xref rid="B16-molecules-30-03516" ref-type="bibr">16</xref>,<xref rid="B17-molecules-30-03516" ref-type="bibr">17</xref>,<xref rid="B18-molecules-30-03516" ref-type="bibr">18</xref>].</p><p>Nickel(II) complexes have demonstrated significant potential in medicinal chemistry due to their biological applications. Studies have shown that nickel(II) complexes can act as therapeutic agents against several diseases, including microbial infections, cancer, and leukemia. These complexes can exhibit antioxidant, anti-inflammatory, antimicrobial, and even cytotoxic activities [<xref rid="B19-molecules-30-03516" ref-type="bibr">19</xref>,<xref rid="B20-molecules-30-03516" ref-type="bibr">20</xref>,<xref rid="B21-molecules-30-03516" ref-type="bibr">21</xref>,<xref rid="B22-molecules-30-03516" ref-type="bibr">22</xref>]. Notably, nickel(II) complexes have been investigated for their interactions with SARS-CoV-2 and HIV pathogens, suggesting their potential as anti-COVID-19 and anti-HIV agents [<xref rid="B23-molecules-30-03516" ref-type="bibr">23</xref>]. Furthermore, these complexes can show cytotoxic effects on tumor and leukemic cells, leading the scientific community to explore the mechanisms involved [<xref rid="B24-molecules-30-03516" ref-type="bibr">24</xref>]. Overall, nickel(II) complexes offer a multifaceted approach to disease treatment, providing promising alternatives for combating a wide range of pathologies. Some published studies exploring the trifluoromethyl group on structures have demonstrated that CF<sub>3</sub> substitution can influence a compound&#8217;s bioactivity. The potential enhancement of biological activity in these molecules can be attributed to increased stability and lipophilicity, making it highly relevant to pharmaceutical chemistry [<xref rid="B25-molecules-30-03516" ref-type="bibr">25</xref>,<xref rid="B26-molecules-30-03516" ref-type="bibr">26</xref>].</p><p>Due to our interest in metal complexes with thiosemicarbazones and dithiocarbazates, we synthesized four new Ni(II) complexes to compare in order to better understand how some structural modifications can influence their physicochemical and pharmacological properties [<xref rid="B17-molecules-30-03516" ref-type="bibr">17</xref>,<xref rid="B18-molecules-30-03516" ref-type="bibr">18</xref>,<xref rid="B27-molecules-30-03516" ref-type="bibr">27</xref>,<xref rid="B28-molecules-30-03516" ref-type="bibr">28</xref>]. In this study, we describe the synthesis and characterization by single-crystal X-ray diffraction, Hirshfeld surface, FT-&#8211;IR, UV&#8211;Vis, mass spectrometry, and <sup>1</sup>H, <sup>19</sup>F, and <sup>31</sup>P nuclear magnetic resonance of thenoyltrifluoroacetone&#8211;4&#8211;phenyl&#8211;3&#8211;thiosemicarbazone (H<sub>2</sub>L<sup>1</sup>) and thenoyltrifluoroacetone&#8211;S&#8211;benzyldithiocarbazate (H<sub>2</sub>L<sup>2</sup>) ligands and their Ni(II) complexes. Furthermore, the biological activity of the compounds was evaluated against three cancer cell lines and one healthy cell line.</p></sec><sec sec-type="results" id="sec2-molecules-30-03516"><title>2. Results and Discussion</title><p>The complexation reactions of the H<sub>2</sub>L<sup>1</sup> and H<sub>2</sub>L<sup>2</sup> ligands with Ni(II) salts yielded the complexes [Ni(L<sup>1</sup>)(PPh<sub>3</sub>)] (<bold>1</bold>), [Ni(L<sup>1</sup>)(Py)] (<bold>2</bold>), [Ni(L<sup>2</sup>)(PPh<sub>3</sub>)] (<bold>3</bold>), and [Ni(L<sup>2</sup>)(Py)] (<bold>4</bold>), with triphenylphosphine or pyridine as coligand to complete the coordination sphere (<xref rid="molecules-30-03516-f002" ref-type="fig">Figure 2</xref>). Crystal structures of (<bold>1</bold>&#8211;<bold>4</bold>) were established by single-crystal X-ray diffraction, and physicochemical and spectroscopic analyses were performed for all compounds.</p><sec id="sec2dot1-molecules-30-03516"><title>2.1. Structural Analyses</title><p>The structural analysis by single-crystal X-ray diffraction of the complexes (<bold>1</bold>&#8211;<bold>4</bold>) revealed the ligand molecules in anionic form coordinated by azomethine nitrogen, carbonyl oxygen, and thiolate sulfur atoms. The coordination sphere for the Ni(II) atoms is completed by triphenylphosphine or pyridine molecules (<xref rid="molecules-30-03516-f003" ref-type="fig">Figure 3</xref>). The coordination geometry proposed for all complexes is a distorted square planar arrangement with trans angles ranging between 174.23(10)&#176; and 178.12(8)&#176;. The Okuniewski parameter [<xref rid="B29-molecules-30-03516" ref-type="bibr">29</xref>] (&#964;4) was used to verify the proposed geometry. When this parameter approaches 0, the geometry is consistent with a square arrangement, whereas values near 1 indicate a tetrahedral configuration. For all complexes, the parameter values ranged between 0.0166 and 0.0221, consistent with the observed distorted square planar geometries and aligning with similar structures [<xref rid="B30-molecules-30-03516" ref-type="bibr">30</xref>,<xref rid="B31-molecules-30-03516" ref-type="bibr">31</xref>]. Selected bond lengths and angles of the complexes (<bold>1</bold>&#8211;<bold>4</bold>) are listed in <xref rid="molecules-30-03516-t001" ref-type="table">Table 1</xref>.</p><p>The bond lengths for the Ni1&#8211;O1 coordination were found to range between 1.854(7) and 1.835(4) &#197;, while Ni1&#8211;N1 bond lengths varied from 1.898(3) to 1.854(8) &#197;. The bond lengths of Ni1&#8211;P for triphenylphosphine are 2.204(10) and 2.209(12) &#197; for (<bold>1</bold>) and (<bold>3</bold>), respectively. The bond lengths of Ni1&#8211;N for pyridine are 1.925(9) and 1.903(4) &#197; for (<bold>2</bold>) and (<bold>4</bold>), respectively. The thiosemicarbazone and dithiocarbazate ligands are coordinated by their <italic toggle="yes">E</italic> isomer and thiol tautomer, as suggested by the bond lengths between 2.112(10) and 2.142(3) &#197;. Bond length values are consistent with those reported for Ni(II) complexes in the literature [<xref rid="B17-molecules-30-03516" ref-type="bibr">17</xref>,<xref rid="B18-molecules-30-03516" ref-type="bibr">18</xref>,<xref rid="B30-molecules-30-03516" ref-type="bibr">30</xref>]. This is evidenced also by the bond lengths of N2&#8211;C9, which range between 1.288(5) and 1.307(13) &#197;, indicating a double-bond character. These values align with those observed in Schiff bases derived from other &#946;-diketones, which exhibit N2&#8211;C9 bond lengths between 1.352(2) and 1.337(13) &#197;. Moreover, the C9&#8211;S2 bond lengths, which range from 1.735(6) to 1.733(3) &#197;, display a single-bond character. Comparatively, free Schiff base ligands derived from &#946;-diketones exhibit shorter C9&#8211;S2 bond lengths, typically ranging from 1.677(19) to 1.645(8) &#197;, as reported in other works. This elongation of the C9&#8211;S2 bond in the complexes further supports their thiol tautomeric coordination [<xref rid="B17-molecules-30-03516" ref-type="bibr">17</xref>,<xref rid="B32-molecules-30-03516" ref-type="bibr">32</xref>,<xref rid="B33-molecules-30-03516" ref-type="bibr">33</xref>]. The crystallographic data also revealed several non-classical intra- and intermolecular hydrogen interactions in the complexes (<bold>1</bold>&#8211;<bold>4</bold>). These interactions contribute to the stabilization of the crystal arrangement of the synthesized complexes, as shown in <xref rid="app1-molecules-30-03516" ref-type="app">Table S1 and Figures S1&#8211;S4 in the Supplementary Materials</xref>. The most observed interactions present in complexes (<bold>1</bold>&#8211;<bold>4</bold>) are non-classical C&#8211;H&#8943;H hydrogen interactions, with distances ranging from 2.381 &#197; to 2.887 &#197;. Additionally, classical N&#8943;H and F&#8943;H interactions are present in the crystal lattice.</p></sec><sec id="sec2dot2-molecules-30-03516"><title>2.2. Hirshfeld Surface</title><p>The Hirshfeld surface (HS) was used to understand and quantify the interactions in the crystal lattice packing of the complexes (<bold>1</bold>&#8211;<bold>4</bold>). HS in the d<sub>norm</sub> function generates a surface that mathematically correlates the distance between an atom within the surface and the closest external atom based on van der Waals radii. This correlation produces a color pattern, ranging from blue to red, which indicates whether the contact distance is bigger, closer, or smaller than the sum of the van der Waals radii of the atoms inside the surface, respectively [<xref rid="B34-molecules-30-03516" ref-type="bibr">34</xref>,<xref rid="B35-molecules-30-03516" ref-type="bibr">35</xref>]. The contacts observed on the surfaces of all four complexes reveal the presence of non-classical hydrogen bonds between atoms (<xref rid="molecules-30-03516-f004" ref-type="fig">Figure 4</xref>). The most frequent intermolecular interactions found in the crystal structures of the complexes were between C&#8211;H&#8943;H&#8211;C, C&#8211;H&#8943;C, C&#8211;H&#8943;F, C&#8211;H&#8943;S, and C&#8211;H&#8943;N.</p><p>The fingerprint plots of complexes (<bold>1</bold>&#8211;<bold>4</bold>) detail the interactions that most contribute to the formation of the crystal lattice, with the main contact contributions being between H&#8943;H and C&#8943;H atoms, presented in the <xref rid="app1-molecules-30-03516" ref-type="app">Supplementary Materials (Figures S5&#8211;S8)</xref> and summarized in <xref rid="molecules-30-03516-f005" ref-type="fig">Figure 5</xref>. The H&#8943;H interactions contribute at 26% and 26.9% in complexes (<bold>2</bold>) and (<bold>4</bold>), respectively, significantly lower than the contributions observed in complexes (<bold>1</bold>) and (<bold>3</bold>) at 43% and 43.8%. This difference can be attributed to the presence of triphenylphosphine molecules coordinated to the metal centers. Furthermore, complexes (<bold>1</bold>) and (<bold>2</bold>) exhibit a higher contribution of H&#8943;N interactions, most likely from the terminal thiosemicarbazone portion in the structures, with contributions ranging between 4.2% and 7.1%. Qualitative and quantitative comparisons of the contacts present in complexes (<bold>1</bold>&#8211;<bold>4</bold>) with similar structures reported in the literature show that these contacts are frequently observed in the supramolecular arrangement of Schiff base-derived complexes [<xref rid="B15-molecules-30-03516" ref-type="bibr">15</xref>,<xref rid="B17-molecules-30-03516" ref-type="bibr">17</xref>,<xref rid="B18-molecules-30-03516" ref-type="bibr">18</xref>,<xref rid="B28-molecules-30-03516" ref-type="bibr">28</xref>,<xref rid="B30-molecules-30-03516" ref-type="bibr">30</xref>,<xref rid="B36-molecules-30-03516" ref-type="bibr">36</xref>,<xref rid="B37-molecules-30-03516" ref-type="bibr">37</xref>].</p></sec><sec id="sec2dot3-molecules-30-03516"><title>2.3. Infrared Spectra</title><p>Infrared spectra were obtained for the ligands and their complexes, ranging from 4000 to 400 cm<sup>&#8722;1</sup> (<xref rid="molecules-30-03516-t002" ref-type="table">Table 2</xref> and <xref rid="app1-molecules-30-03516" ref-type="app">Figures S9&#8211;S14</xref>).</p><p>The IR spectrum of the free ligands showed the &#957;(N&#8211;H) of the nitrogen adjacent to the azomethine group at 3333 and 3304 cm<sup>&#8722;1</sup> for H<sub>2</sub>L<sup>1</sup> and 3195 cm<sup>&#8722;1</sup> for H<sub>2</sub>L<sup>2</sup>. Additionally, both ligands exhibited a characteristic &#957;(C=O) at 1651 cm<sup>&#8722;1</sup> for H<sub>2</sub>L<sup>1</sup> and 1637 cm<sup>&#8722;1</sup> for H<sub>2</sub>L<sup>2</sup> [<xref rid="B17-molecules-30-03516" ref-type="bibr">17</xref>,<xref rid="B30-molecules-30-03516" ref-type="bibr">30</xref>,<xref rid="B32-molecules-30-03516" ref-type="bibr">32</xref>,<xref rid="B33-molecules-30-03516" ref-type="bibr">33</xref>,<xref rid="B38-molecules-30-03516" ref-type="bibr">38</xref>]. Comparing the spectra of the free ligands and their Ni(II) complexes, the disappearance of the &#957;(C=O) and &#957;(N&#8211;H) bands was observed, indicating the formation of the enol tautomer with the complexation. In the absence of water molecules in complexes (<bold>2</bold>) and (<bold>4</bold>), the bands observed from 3450 to 3438 cm<sup>&#8722;1</sup> can be attributed to moisture adsorbed by the KBr pellets during sample preparation. Another significant observation is the absence of the intense &#957;(C=S) in the complexes. This absence is attributed to the coordination of the sulfur atom with the Ni(II) atoms, which transforms this bond into a single bond, as corroborated by single-crystal X-ray diffraction results. This behavior is in agreement with the literature, where the sulfur atoms of the ligands transfer part of their electron density to the metal upon complexation, weakening the sulfur&#8211;carbon bond [<xref rid="B15-molecules-30-03516" ref-type="bibr">15</xref>,<xref rid="B17-molecules-30-03516" ref-type="bibr">17</xref>,<xref rid="B27-molecules-30-03516" ref-type="bibr">27</xref>,<xref rid="B30-molecules-30-03516" ref-type="bibr">30</xref>,<xref rid="B32-molecules-30-03516" ref-type="bibr">32</xref>,<xref rid="B38-molecules-30-03516" ref-type="bibr">38</xref>].</p><p>In the free H<sub>2</sub>L<sup>1</sup> ligand, the &#957;(C=N) is observed at 1597 cm<sup>&#8722;1</sup>, while in both complexes (<bold>1</bold>) and (<bold>2</bold>) it is at 1544 cm<sup>&#8722;1</sup>. This shift is justified by the increased electron delocalization in the structures of the metal complexes, as supported by single-crystal X-ray diffraction results, which show the double-bond character of the C=N bond [<xref rid="B17-molecules-30-03516" ref-type="bibr">17</xref>,<xref rid="B28-molecules-30-03516" ref-type="bibr">28</xref>,<xref rid="B39-molecules-30-03516" ref-type="bibr">39</xref>]. For &#957;(N&#8211;N), an increase in the stretching frequency is observed in complexes compared to the free ligand, with values ranging from 1097 to 1066 cm<sup>&#8722;1</sup> for the complexes and from 1064 cm<sup>&#8722;1</sup> to 1038 cm<sup>&#8722;1</sup> for the ligands, respectively [<xref rid="B27-molecules-30-03516" ref-type="bibr">27</xref>,<xref rid="B28-molecules-30-03516" ref-type="bibr">28</xref>]. Based on the similarity with other nickel(II) complexes with Schiff bases and pyridine or triphenylphosphine reported in the literature, the bands in the 690&#8211;694 cm<sup>&#8722;1</sup> region can be assigned to &#948;(Py) and &#957;(Ni&#8211;PPh<sub>3</sub>) vibrations [<xref rid="B18-molecules-30-03516" ref-type="bibr">18</xref>,<xref rid="B30-molecules-30-03516" ref-type="bibr">30</xref>,<xref rid="B31-molecules-30-03516" ref-type="bibr">31</xref>].</p></sec><sec id="sec2dot4-molecules-30-03516"><title>2.4. Electronic Spectra</title><p>The electronic spectra of the Schiff bases and their complexes (<bold>1</bold>&#8211;<bold>4</bold>) were obtained to investigate the possible electronic transitions at concentrations of 2 &#215; 10<sup>&#8722;5</sup> mol&#183;L<sup>&#8722;1</sup> in methanol and dimethylformamide (<xref rid="app1-molecules-30-03516" ref-type="app">Figures S15&#8211;S18</xref>). The wavelengths representing &#960;&#8211;&#960;* transitions of the azomethine group, n&#8211;&#960;* transitions, and ligand&#8211;metal charge transfer (LMCT) transitions are listed in <xref rid="molecules-30-03516-t003" ref-type="table">Table 3</xref>.</p><p>All compounds exhibited bands in high-energy regions, attributed to the &#960;&#8594;&#960;* transition of the azomethine function. In the ligands, these values ranged between 283&#8211;284 nm for H<sub>2</sub>L<sup>1</sup> and 262&#8211;294 nm for H<sub>2</sub>L<sup>2</sup>. In the complexes, a decrease in the wavelength of this transition was observed, indicating a hypochromic shift upon complexation, with values between 229&#8211;281 nm [<xref rid="B40-molecules-30-03516" ref-type="bibr">40</xref>]. For the ligands H<sub>2</sub>L<sup>1</sup> and H<sub>2</sub>L<sup>2</sup> in methanol, n&#8594;&#960;* transitions were observed at wavelengths of 415 nm and 445 nm, respectively, while in dimethylformamide, these transitions were found at 431 nm and 451 nm. The complexes exhibited broad bands in the range of 441&#8211;501 nm, attributed to charge transfer S&#8594;Ni(II), as seen in other studies, suggesting the coordination by the thiolate group [<xref rid="B17-molecules-30-03516" ref-type="bibr">17</xref>,<xref rid="B30-molecules-30-03516" ref-type="bibr">30</xref>,<xref rid="B38-molecules-30-03516" ref-type="bibr">38</xref>,<xref rid="B41-molecules-30-03516" ref-type="bibr">41</xref>]. Furthermore, the complexes formed with the thiosemicarbazone ligand exhibited several ligand-to-metal charge transfer transitions, whereas the complexes with the dithiocarbazate ligand exhibited fewer such transitions. The d-d transitions for Ni(II) typically occur in the visible region of the spectrum. Still, distinct d-d transitions were not observed in the complexes, presumably due to their low intensity and overlap with the more intense ligand-based and LMCT bands. Despite the high structural similarity, small variations in the ligands can alter the molecular configuration, affecting the optical properties and intermolecular interactions and causing variations in the number of observable peaks in the UV&#8211;visible spectrum.</p></sec><sec id="sec2dot5-molecules-30-03516"><title>2.5. Mass Spectrometry</title><p>Electrospray ionization mass spectra in positive mode ESI(+)&#8211;MS(/MS) were acquired to investigate the actual species present in solution for H<sub>2</sub>L<sup>1</sup>, H<sub>2</sub>L<sup>2</sup>, and their complexes (<bold>1</bold>&#8211;<bold>4</bold>) at a concentration of 50 &#956;M (<xref rid="app1-molecules-30-03516" ref-type="app">Figures S19&#8211;S28</xref>). The ESI(+)&#8211;MS/MS spectrum for the ligand H<sub>2</sub>L<sup>1</sup> peaks at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 372.0450, corresponding to the [M+H]<sup>+</sup> ion. In contrast, the base peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 246.0310 was attributed to the loss of the &#946;-diketone moiety containing the thiophene group. Additional fragment ions were identified at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 219.0198, assigned to the loss of both the thiophene and CF<sub>3</sub> groups from the &#946;-diketone, along with signals corresponding to the terminal thiosemicarbazone moiety and half of the &#946;-diketone at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 136.0216 and <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 110.99606, respectively. Similarly, H<sub>2</sub>L<sup>2</sup> displayed a peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 403.1103, representing the [M+H]<sup>+</sup> ion, and a base peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 277.0072, corresponding with partial &#946;-diketone loss containing the thiophene group. Fragment peaks at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 110.9906, corresponding to the half &#946;-diketone, and <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 91.00561, attributed to the loss of the S-benzyl moiety from the dithiocarbazate, were detected.</p><p>Complexes (<bold>1</bold>) and (<bold>2</bold>), due to their structural similarity, exhibited similar fragmentation patterns in their ESI(+)&#8211;MS/MS spectra. For (<bold>1</bold>), a peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 690.0576 was observed, corresponding to the [M+H]<sup>+</sup> ion, with the base peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 427.9650 attributed to the loss of the triphenylphosphine coligand (<xref rid="molecules-30-03516-f006" ref-type="fig">Figure 6</xref>). Complex (<bold>2</bold>) exhibited a peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 507.3280 for the [M+H]<sup>+</sup> ion and a base peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 427.9645, associated with the loss of the pyridine group. In both spectra, the presence of the deprotonated free ligand was observed at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 368.9810, along with a fragment corresponding to the ligand without the terminal thiosemicarbazone moiety at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 208.9669. Additionally, peaks corresponding to triphenylphosphine at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 263.0982 for complex (<bold>1</bold>) and pyridine at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 80.0512 for complex (<bold>2</bold>) were observed [<xref rid="B17-molecules-30-03516" ref-type="bibr">17</xref>].</p><p>Due to their structural similarity, the complexes with dithiocarbazate ligands exhibited analogous fragmentation patterns. In the ESI(+)&#8211;MS/MS spectrum of (<bold>3</bold>), a peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 721.0333 was observed for the [M+H]<sup>+</sup> ion, while the base peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 458.9412 was attributed to the loss of the triphenylphosphine coligand. The ESI(+)&#8211;MS/MS of (<bold>4</bold>) displayed a peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 537.9815 for the [M+H]<sup>+</sup> ion, with the base peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 458.9400 corresponding to the loss of the pyridine group (<xref rid="molecules-30-03516-f007" ref-type="fig">Figure 7</xref>). Both spectra showed a fragment peak at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 91.0552, assigned to the terminal dithiocarbazate moiety, along with triphenylphosphine at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 263.0984 for (<bold>3</bold>) and pyridine at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 80.0520 for (<bold>4</bold>) [<xref rid="B17-molecules-30-03516" ref-type="bibr">17</xref>]. The isotopic distribution patterns observed in the ESI(+)&#8211;MS spectra strongly support the proposed structures of the synthesized compounds, as the experimental data demonstrated excellent agreement with theoretical values [<xref rid="B42-molecules-30-03516" ref-type="bibr">42</xref>].</p></sec><sec id="sec2dot6-molecules-30-03516"><title>2.6. <sup>1</sup>H, <sup>19</sup>F, and <sup>31</sup>P NMR Spectra</title><p>The <sup>1</sup>H NMR spectra of the synthesized ligands and complexes (<bold>1</bold>&#8211;<bold>4</bold>) are presented in <xref rid="app1-molecules-30-03516" ref-type="app">Figures S28&#8211;S33</xref>, while the corresponding chemical shift values and coupling constants (J) are summarized in <xref rid="molecules-30-03516-t004" ref-type="table">Table 4</xref> and <xref rid="app1-molecules-30-03516" ref-type="app">Table S2&#8211;S7</xref>. In all compounds, the most shielded signals in the spectra correspond to singlets attributed to CH<sub>2</sub> groups, with chemical shifts ranging from 4.46 ppm to 4.67 ppm in the ligands and from 4.10 ppm to 4.33 ppm in the complexes (<bold>3</bold>) and (<bold>4</bold>), associated with the terminal dithiocarbazate moiety. Upon complex formation, deprotonation of the C6 carbon occurs, leading to electronic delocalization throughout the structure due to coordination with the metal center [<xref rid="B27-molecules-30-03516" ref-type="bibr">27</xref>,<xref rid="B41-molecules-30-03516" ref-type="bibr">41</xref>,<xref rid="B43-molecules-30-03516" ref-type="bibr">43</xref>]. This delocalization reduces the electron density on the remaining hydrogen atom bound to this carbon, increasing its unshielding effect and shifting the signal to higher chemical shift values [<xref rid="B27-molecules-30-03516" ref-type="bibr">27</xref>,<xref rid="B41-molecules-30-03516" ref-type="bibr">41</xref>,<xref rid="B43-molecules-30-03516" ref-type="bibr">43</xref>]. In complexes (<bold>1</bold>) and (<bold>2</bold>), this shift was observed at 6.26 ppm and 6.17 ppm, respectively, whereas in complexes (<bold>3</bold>) and (<bold>4</bold>), these signals overlapped with the aromatic region. Regarding the most unshielded chemical environments, the hydrogen atoms were attributed to the amino groups in the ligands, with chemical shifts at 11.19 ppm and 13.20 ppm for H<sub>2</sub>L<sup>1</sup> and H<sub>2</sub>L<sup>2</sup>, respectively [<xref rid="B22-molecules-30-03516" ref-type="bibr">22</xref>,<xref rid="B28-molecules-30-03516" ref-type="bibr">28</xref>,<xref rid="B33-molecules-30-03516" ref-type="bibr">33</xref>]. The remaining signals were attributed to aromatic hydrogen atoms. Although some of these aromatic hydrogens are chemically non-equivalent, their signals appeared in the same regions. The <sup>19</sup>F NMR spectra of all compounds are presented in <xref rid="app1-molecules-30-03516" ref-type="app">Figure S35</xref>; the spectra display characteristic chemical shifts for the trifluoromethyl group in the range of &#8722;62.04 to &#8722;68.40 ppm, consistent with values reported for analogous CF<sub>3</sub>-containing compounds in the literature [<xref rid="B44-molecules-30-03516" ref-type="bibr">44</xref>,<xref rid="B45-molecules-30-03516" ref-type="bibr">45</xref>]. The <sup>31</sup>P NMR spectra of the free PPh<sub>3</sub> and the ligands and complexes (<bold>1</bold>) and (<bold>3</bold>), shown in <xref rid="app1-molecules-30-03516" ref-type="app">Figure S36</xref>, exhibit a downfield-shifted singlet at 22.92 and 22.30 ppm, respectively, for (<bold>1</bold>) and (<bold>3</bold>), consistent with the presence of a single coordinated triphenylphosphine ligand in the nickel(II) complexes. These chemical shifts align with those reported for analogous Ni(II)-PPh<sub>3</sub> systems, confirming the expected coordination environment [<xref rid="B46-molecules-30-03516" ref-type="bibr">46</xref>,<xref rid="B47-molecules-30-03516" ref-type="bibr">47</xref>].</p></sec><sec id="sec2dot7-molecules-30-03516"><title>2.7. Biological Activity Analysis</title><p>DMSO solutions (10<sup>&#8722;3</sup> M) of the complexes (<bold>1</bold>&#8211;<bold>4</bold>) were subjected to molar conductance measurements at room temperature over 48 h, and the observed values are presented in <xref rid="app1-molecules-30-03516" ref-type="app">Table S8</xref>. The complexes showed low molar conductance values, which indicates that they are present in their neutral form. A comparative cytotoxicity assay explored the differences between nickel(II) complexes derived from thiosemicarbazone and dithiocarbazate ligands. Additionally, we investigated the influence of the coligands triphenylphosphine and pyridine in the complexes. The effectiveness of the compounds in inhibiting cell viability was concentration- and time-dependent. The analysis involved varying concentrations between 1.56 and 200 &#181;M over 48 h using an MTT assay, with untreated cells serving as the control. <xref rid="molecules-30-03516-t005" ref-type="table">Table 5</xref> presents the IC<sub>50</sub> values for the free ligands, synthesized complexes, and cisplatin, which served as reference compounds in this study [<xref rid="B48-molecules-30-03516" ref-type="bibr">48</xref>]. The compounds&#8217; proliferative ability in 48 h was significantly reduced with increasing concentration (<xref rid="molecules-30-03516-f008" ref-type="fig">Figure 8</xref>).</p><p>For the MCF-7 breast cancer cell line, no cytotoxic activity was observed for the free ligands at concentrations below 100 &#181;M. In contrast, only the complexes containing pyridine as a coligand exhibited cytotoxic activity, with IC<sub>50</sub> values of 8.48 &#181;M for complex (<bold>2</bold>) and 56.54 &#181;M for complex (<bold>4</bold>). In the cisplatin-resistant ovarian cancer cell line A2780cis, both free ligands demonstrated cytotoxic activity with IC<sub>50</sub> values of 42.78 &#181;M and 78.93 &#181;M for H<sub>2</sub>L<sup>1</sup> and H<sub>2</sub>L<sup>2</sup>, respectively. Upon complexation, an increase in cytotoxic activity was observed when pyridine was used as the coligand, whereas the use of triphenylphosphine resulted in reduced cytotoxicity. For the A549 lung cancer cell line, cytotoxic activity was observed only for the thiosemicarbazone ligand and complex (<bold>2</bold>) with IC<sub>50</sub> values of 51.38 &#181;M and 27.18 &#181;M, respectively, indicating enhanced cytotoxicity upon coordination. For the nontumoral lung cell line MRC-5, only complex (<bold>2</bold>) showed an IC<sub>50</sub> value of 9.89 &#181;M.</p><p>The results demonstrate that Ni(II) complexes containing pyridine groups exhibited greater cytotoxic activity than those with triphenylphosphine, similar to related complexes [<xref rid="B17-molecules-30-03516" ref-type="bibr">17</xref>,<xref rid="B30-molecules-30-03516" ref-type="bibr">30</xref>]. This indicates that bulky groups coordinated to the metal centers may increase lipophilicity by reducing their bioavailability [<xref rid="B17-molecules-30-03516" ref-type="bibr">17</xref>,<xref rid="B31-molecules-30-03516" ref-type="bibr">31</xref>]. In addition, the cytotoxicity of the synthesized compounds against the A2780cis cell line is particularly noteworthy, as this cell line has demonstrated resistance to cisplatin-based treatments [<xref rid="B49-molecules-30-03516" ref-type="bibr">49</xref>]. The synthesized compounds H<sub>2</sub>L<sup>1</sup>, H<sub>2</sub>L<sup>2</sup>, and complexes (<bold>2</bold>) and (<bold>4</bold>) may represent promising candidates for alternative therapies, as they exhibit cytotoxic activity against this cisplatin-resistant cell line while demonstrating lower toxicity to healthy cells, such as MRC-5. Although MRC-5 represents a different tissue type, the results suggest a degree of selectivity of these compounds towards tumor cells, except for complex (<bold>2</bold>), which was the only compound with an IC<sub>50</sub> value below 100 &#181;M. While complex (<bold>2</bold>) demonstrates prominent cytotoxicity against MCF-7 and A2780cis cell lines, its comparable toxicity toward nontumoral MRC-5 lung cells indicates limited therapeutic selectivity. In contrast, complex 4 shows moderate tumor cell inhibition with no observable toxicity to MRC-5 cells at &#8804;100 &#956;M, suggesting a potentially safer pharmacological profile despite reduced potency. This contrast highlights the balance between efficacy and selectivity in drug development.</p></sec></sec><sec id="sec3-molecules-30-03516"><title>3. Materials and Methods</title><sec id="sec3dot1-molecules-30-03516"><title>3.1. Materials, Methods, and Instruments</title><p>The reagents and solvents were obtained from Merck-Brazil and used without further purification. The complexation studies were performed using fresh pyridine. The FT&#8211;IR spectra of the compounds were obtained from KBr pellets using an FT&#8211;IR Varian 640 spectrometer (Agilent Technologies, Santa Clara, CA, USA) in the range of 4000&#8211;400 cm<sup>&#8722;1</sup>, with 32 scans at a resolution of 4 cm<sup>&#8722;1</sup>. Electrospray ionization&#8211;mass spectrometry analysis (ESI&#8211;MS) was performed on an AB Sciex Triple TOF 5600+ mass spectrometer (SCIEX, Marlborough, MA, USA) in positive mode, with a voltage of 5500 V and source temperature of 200 &#176;C. <sup>1</sup>H, <sup>19</sup>F, and <sup>31</sup>P nuclear magnetic resonance spectra were collected on a Bruker Ascend 600 MHz (UC Davis RMN Facility, Davis, CA, USA), with TMS as internal reference and DMSO&#8211;<italic toggle="yes">d<sub>6</sub></italic> as solvent for <sup>1</sup>H experiments and PF<sub>6</sub> as intermetal reference and D<sub>2</sub>O as solvent for <sup>19</sup>F and <sup>31</sup>P experiments. Elemental analysis of CHN was performed with a Perkin Elmer/Series II 2400 analyzer (Perkin Elmer, Shelton, CT, USA). The reported elemental analysis values are from a single measurement, even though the analysis was performed in triplicate. Electronic spectra were obtained using a UV&#8211;Vis&#8211;NIR Varian Cary 5000 spectrophotometer (Agilent Technologies, Santa Clara, CA, USA) using 20 &#956;M solutions prepared in methanol and dimethylformamide. Complexes (<bold>1</bold>&#8211;<bold>4</bold>) were synthesized based on procedures previously described for similar compounds [<xref rid="B17-molecules-30-03516" ref-type="bibr">17</xref>,<xref rid="B18-molecules-30-03516" ref-type="bibr">18</xref>,<xref rid="B30-molecules-30-03516" ref-type="bibr">30</xref>].</p></sec><sec id="sec3dot2-molecules-30-03516"><title>3.2. Synthesis of Thiosemicarbazone Ligand (H<sub>2</sub>L<sup>1</sup>)</title><p>H<sub>2</sub>L<sup>1</sup> was synthesized based on a patterning procedure [<xref rid="B50-molecules-30-03516" ref-type="bibr">50</xref>]. An amount of 666.57 mg (3 mmol) of thenoyltrifluoroacetone was added to an ethanolic solution (40 mL) of 501.69 mg (3 mmol) of 4&#8211;phenyl&#8211;thiosemicarbazide and was stirred under reflux for 4 h with a few drops of H<sub>2</sub>SO<sub>4</sub>. Yellow crystals suitable for X-ray diffraction were obtained and filtered after slow evaporation of the solvent of the mother solution. Yield: 1017 mg (91.4%). Melting point: 186&#8211;187 &#176;C. Elemental analysis calculated for C<sub>15</sub>H<sub>12</sub>F<sub>3</sub>N<sub>3</sub>OS<sub>2</sub> (%): C. 48.51; H. 3.26; N. 11.31. Found (%): C. 48.82; H. 3.69; N. 11.56. IR bands (KBr, &#957;/cm<sup>&#8722;1</sup>): &#957;(N&#8211;H) 3333 and 3304; &#957;(C=N) 1597; &#957;(C=S) 1307; &#957;(N&#8211;N) 1038; &#957;(C&#8211;S) 728. <sup>1</sup>H NMR (DMSO&#8211;d<sub>6</sub>, ppm): 11.72 (s, 1H, N&#8211;H), 10.19 (s, 1H, N&#8211;H), 8.12&#8211;8.10 (m, 1H, &#8211;CH), 8.10&#8211;8.08 (m, 1H, &#8211;CH), 7.53 (d, 1H, Ar), 7.39 (dd, 1H, Ar), 7.33 (dd, 1H, Ar), 7.25 (t, 1H, Ar), 4.67 (s, 2H, CH<sub>2</sub>). <sup>19</sup>F NMR (D<sub>2</sub>O, ppm): &#8722;67.57 (s, CF<sub>3</sub>). <sup>31</sup>P NMR (D<sub>2</sub>O, ppm): &#8722;6.50 (s, PPh<sub>3</sub>-free). UV&#8211;vis (MeOH): &#955;max = 284 nm and 415 nm. UV&#8211;vis (DMF): &#955;max = 283 nm and 431 nm. ESI&#8211;MS [M+H]<sup>+</sup> (calcd, found, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic>) = 372.0447/372.0449.</p></sec><sec id="sec3dot3-molecules-30-03516"><title>3.3. Synthesis of Dithiocarbazate Ligand (H<sub>2</sub>L<sup>2</sup>)</title><p>H<sub>2</sub>L<sup>2</sup> was obtained following the procedures in the related literature [<xref rid="B33-molecules-30-03516" ref-type="bibr">33</xref>,<xref rid="B51-molecules-30-03516" ref-type="bibr">51</xref>]. A mixture of 0.194 mL (1 mmol) of hydrazine hydrate and 56.1 mg (1 mmol) of KOH in 15 mL of ethanol was cooled to 5 &#176;C and refluxed for 1 h. In this solution, 0.06 mL (1 mmol) of carbon disulfide is used. The mixture was kept in an ice bath, and 0.12 mL of benzyl bromide was added dropwise with vigorous stirring. After 1 h, 222.19 mg of thenoyltrifluoroacetone was added, and the final mixture was refluxed and heated for 1 h. Yellow crystals were obtained after some days with the evaporation of the mother solution at room temperature. Yield: 56.2 mg (14%). Melting point: 101 &#176;C. Elemental analysis calculated for C<sub>16</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>OS<sub>3</sub> (%): C. 47.75; H. 3.26; N. 6.96. Found (%): C. 47.43; H. 3.26; N. 7.27. IR bands (KBr, &#957;/cm<sup>&#8722;1</sup>): &#957;(N&#8211;H) 3108; &#957;(C=N) 1594; &#957;(C=S) 1306; &#957;(N&#8211;N) 1064; &#957;(C&#8211;S) 732. <sup>1</sup>H NMR (DMSO&#8211;d<sub>6</sub>, ppm): 13.20 (s, 1H, N&#8211;H), 8.10 (d, 1H, &#8211;CH), 8.07 (d, 1H, &#8211;CH), 7.42 (d, 1H, Ar), 7.36&#8211;7.27 (m, 4H, Ar), 4.65 (s, 2H, &#8211;CH<sub>2</sub>), 4.46 (s, 2H, CH<sub>2</sub>). <sup>19</sup>F NMR (D<sub>2</sub>O, ppm): &#8722;68.40 (s, CF<sub>3</sub>). <sup>31</sup>P NMR (D<sub>2</sub>O, ppm): &#8722;6.50 (s, PPh<sub>3</sub>-free). UV&#8211;vis (MeOH): &#955;max = 262 nm, 295 nm, and 445 nm. UV&#8211;vis (DMF): &#955;max = 294 nm and 451 nm. ESI&#8211;MS [M+H]<sup>+</sup> (calcd, found, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic>) = 403.0215/403.0213.</p></sec><sec id="sec3dot4-molecules-30-03516"><title>3.4. Synthesis of [Ni(L<sup>1</sup>)(PPh<sub>3</sub>)] (<bold><italic toggle="yes">1</italic></bold>)</title><p>Initially, 52 mg (0.2 mmol) of triphenylphosphine was dissolved in 5 mL of methanol and added to a solution of 23.7 mg (0.1 mmol) of NiCl<sub>2</sub>&#183;6H<sub>2</sub>O in 5 mL of methanol, and the mixture was refluxed for 10 min. Subsequently, a solution of H<sub>2</sub>L<sup>1</sup> (37.1 mg, 0.1 mmol) in 5 mL of methanol was added, and the reaction was continued under reflux for 2 h. Red crystals appropriate for single-crystal X-ray diffraction analysis were filtered off from the mother solution. Yield: 47.1 mg (68.3%). Melting point: 204&#8211;205 &#176;C. Elemental analysis calculated for C<sub>33</sub>H<sub>25</sub>F<sub>3</sub>N<sub>3</sub>OS<sub>2</sub>PNi (%): C. 57.41; H. 3.65; N. 6.09. Found (%): C. 57.42; H. 3.34; N. 6.07. IR bands (KBr, &#957;/cm<sup>&#8722;1</sup>): &#957;(C=N) 1544; &#957;(C=C) 1506 and 1434; &#957;(N&#8211;N) 1097; &#957;(C&#8211;S) 746; &#957;(PPh<sub>3</sub>) 692. <sup>1</sup>H NMR (DMSO&#8211;d<sub>6</sub>, ppm): 9.40 (s, 1H, N&#8211;H), 7.78 (t, 6H, PPh<sub>3</sub>), 7.64&#8211;7.51 (m, 13H, Ar and PPh<sub>3</sub>), 7.20 (t, 2H, Ar), 6.92&#8211;6.89 (m, 1H, &#8211;CH), 6.87 (t, 1H, Ar), 6.26 (s, 1H, &#8211;CH). <sup>19</sup>F NMR (D<sub>2</sub>O, ppm): &#8722;63.63 (s, CF<sub>3</sub>). <sup>31</sup>P NMR (D<sub>2</sub>O, ppm): 22.92 (s, PPh<sub>3</sub>). UV&#8211;vis (MeOH): &#955;max = 229 nm, 273 nm, 361 nm, 464 nm, and 494 nm. UV&#8211;vis (DMF): &#955;max = 445 nm, 469 nm, and 500 nm. ESI&#8211;MS [M+H]<sup>+</sup> (calcd, found, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic>) = 690.0555/690.0563.</p></sec><sec id="sec3dot5-molecules-30-03516"><title>3.5. Synthesis of [Ni(L<sup>1</sup>)(Py)] (<bold><italic toggle="yes">2</italic></bold>)</title><p>The complex was synthesized by reaction of pyridine (16 &#956;L, 0.2 mmol) in ethanol (5 mL) with Ni(Ac)<sub>2</sub>&#183;4H<sub>2</sub>O (24.8 mg, 0.1 mmol) in ethanol (5 mL). The mixture was refluxed for 10 min, followed by the addition of H<sub>2</sub>L<sup>1</sup> (37.1 mg, 0.1 mmol) in ethanol (5 mL). The resulting solution was then refluxed for 2 h. Red crystals appropriate for single-crystal X-ray diffraction analysis were obtained in the refrigerator and filtered from the mother solution. Yield: 34.3 mg (67.8%). Melting point: 149&#8211;150 &#176;C. Elemental analysis calculated for C<sub>20</sub>H<sub>15</sub>F<sub>3</sub>N<sub>4</sub>OS<sub>2</sub>Ni (%): C. 47.36; H. 2.98; N. 11.05. Found (%): C. 47.20; H. 2.68; N. 10.83. IR bands (KBr, &#957;/cm<sup>&#8722;1</sup>): &#957;(C=N) 1544; &#957;(C=C) 1510 and 1413; &#957;(N&#8211;N) 1066; &#957;(C&#8211;S) 746; &#948;(Py) 694. <sup>1</sup>H NMR (DMSO&#8211;d<sub>6</sub>, ppm): 9.40 (s, 1H, N&#8211;H), 9.06 (s, 2H, &#8211;CH Py), 8.04 (s, 1H, &#8211;CH Py), 7.72&#8211;7.51 (m, 6H, Ar and Py), 7.21 (t, 2H, Ar), 7.14&#8211;7.07 (m, 1H, &#8211;CH), 6.88 (t, 1H, Ar), 6.17 (s, 1H, &#8211;CH). <sup>19</sup>F NMR (D<sub>2</sub>O, ppm): &#8722;63.13 (s, CF<sub>3</sub>). UV&#8211;vis (MeOH): &#955;max = 257 nm, 333 nm, 441 nm, 444 nm, and 499 nm. UV&#8211;vis (DMF): &#955;max = 281, nm, 444 nm, 469 nm, and 501 nm. ESI&#8211;MS [M+H]<sup>+</sup> (calcd, found, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic>) = 507.0065/507.0064.</p></sec><sec id="sec3dot6-molecules-30-03516"><title>3.6. Synthesis of [Ni(L<sup>2</sup>)(PPh<sub>3</sub>)] (<bold><italic toggle="yes">3</italic></bold>)</title><p>Triphenylphosphine (52 mg, 0.2 mmol) was dissolved in methanol (5 mL) and added to a solution of NiCl<sub>2</sub>&#183;6H<sub>2</sub>O (23.7 mg, 0.1 mmol) in methanol (5 mL). The mixture was refluxed for 10 min. Subsequently, H<sub>2</sub>L<sup>2</sup> (40.4 mg, 0.1 mmol) in methanol (5 mL) was added directly to the reaction mixture, and reflux was continued for 2 h. Red crystals appropriate for single-crystal X-ray diffraction analysis were obtained in the refrigerator and filtered off from the mother solution. Yield: 54.1 mg (75.1%). Melting point: 182&#8211;183 &#176;C. Elemental analysis calculated for C<sub>34</sub>H<sub>26</sub>F<sub>3</sub>N<sub>2</sub>OPS<sub>3</sub>Ni (%): C. 56.61; H. 3.63; N. 3.88. Found (%): C. 56.88; H. 3.59; N. 4.02. IR bands (KBr, &#957;/cm<sup>&#8722;1</sup>): &#957;(C=N) 1527; &#957;(C=C) 1400; &#957;(N&#8211;N) 1095; &#957;(CSS) 991; &#957;(C&#8211;S) 746; &#957;(PPh<sub>3</sub>) 692. <sup>1</sup>H NMR (DMSO&#8211;d<sub>6</sub>, ppm): 7.80&#8211;7.65 (m, 6H, PPh<sub>3</sub>), 7.65&#8211;7.42 (m, 13H, Ar and PPh<sub>3</sub>), 7.34&#8211;7.29 (m, 4H, Ar), 7.29&#8211;7.22 (m, 1H, Ar), 4.33 (s, 2H, &#8211;CH<sub>2</sub>). <sup>19</sup>F NMR (D<sub>2</sub>O, ppm): &#8722;62.04 (s, CF<sub>3</sub>). <sup>31</sup>P NMR (D<sub>2</sub>O, ppm): 22.30 (s, PPh<sub>3</sub>). UV&#8211;vis (MeOH): &#955;max = 251 nm, 275 nm, and 449 nm. UV&#8211;vis (DMF): &#955;max = 445 nm. ESI&#8211;MS [M+H]<sup>+</sup> (calcd, found, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic>) = 721,0323/721,0316.</p></sec><sec id="sec3dot7-molecules-30-03516"><title>3.7. Synthesis of [Ni(L<sup>2</sup>)(Py)] (<bold><italic toggle="yes">4</italic></bold>)</title><p>Complex <bold>4</bold> was synthesized by reacting pyridine (16 &#956;L, 0.2 mmol) in methanol (5 mL) with NiCl<sub>2</sub>&#183;6H<sub>2</sub>O (23.7 mg, 0.1 mmol) in methanol (5 mL). The mixture was refluxed for 10 min, followed by the addition of H<sub>2</sub>L<sup>2</sup> (40.4 mg, 0.1 mmol) in methanol (5 mL). The resulting solution was then refluxed for 2 h. Red crystals appropriate for single-crystal X-ray diffraction analysis were filtered from the mother solution. Yield: 37.9 mg (70.7%). Melting point: 152&#8211;154 &#176;C. Elemental analysis calculated for C<sub>21</sub>H<sub>15</sub>F<sub>3</sub>N<sub>3</sub>OS<sub>3</sub>Ni (%): C. 46.95; H. 2.81; N. 7.82. Found (%): C. 46.51; H. 3.02; N. 7.73. IR bands (KBr, &#957;/cm<sup>&#8722;1</sup>): &#957;(C=N) 1529; &#957;(C=C) 1405; &#957;(CSS) 991; &#957;(C&#8211;S) 759; &#948;(Py) 694. <sup>1</sup>H NMR (DMSO&#8211;d<sub>6</sub>, ppm): 10.39 (s, 2H, Py), 8.16&#8211;7.79 (m, 13H, Ar and Py), 7.46&#8211;7.37 (m, 1H, Ar), 7.37&#8211;7.26 (m, 4H, Ar), 7.26&#8211;7.15 (m, 1H, Ar), 4.10 (s, 2H, &#8211;CH<sub>2</sub>). <sup>19</sup>F NMR (D<sub>2</sub>O, ppm): &#8722;62.33 (s, CF<sub>3</sub>). UV&#8211;vis (MeOH): &#955;max = 257 nm and 454 nm. UV&#8211;vis (DMF): &#955;max = 455 nm. ESI&#8211;MS [M+H]<sup>+</sup> (calcd, found, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic>) = 537.9833/537.9813.</p></sec><sec id="sec3dot8-molecules-30-03516"><title>3.8. Crystal Structure Determination</title><p>The X-ray data collection was performed on a Bruker CCD SMART APEX II single-crystal diffractometer with Mo K&#945; radiation (0.71073 &#197;) at room temperature (296 K). The collected data were processed with SAINT [<xref rid="B52-molecules-30-03516" ref-type="bibr">52</xref>], and SADABS [<xref rid="B53-molecules-30-03516" ref-type="bibr">53</xref>] was used for absorption correction. The structures were solved with direct methods using the SHELXS program [<xref rid="B54-molecules-30-03516" ref-type="bibr">54</xref>], and the positions of the nonhydrogen atoms were determined with subsequent Fourier difference map analyses. The refinement was accomplished with SHELXL&#8211;2018 using least squares minimization [<xref rid="B55-molecules-30-03516" ref-type="bibr">55</xref>]. The Olex2 program [<xref rid="B56-molecules-30-03516" ref-type="bibr">56</xref>] was used for the solution and refinement of the structures. Molecular graphics were generated via MERCURY 2024.2.0 software [<xref rid="B57-molecules-30-03516" ref-type="bibr">57</xref>]. <xref rid="app1-molecules-30-03516" ref-type="app">Table S9</xref> summarizes the crystal data, experimental details, and refinement results.</p></sec><sec id="sec3dot9-molecules-30-03516"><title>3.9. Hirshfeld Surface</title><p>The Hirshfeld surfaces (HS) and the 2D fingerprint plots (FP) of the complexes (<bold>1</bold>&#8211;<bold>4</bold>) were generated using the software CrystalExplorer 21.5 [<xref rid="B35-molecules-30-03516" ref-type="bibr">35</xref>]. The crystallographic information files (CIFs) obtained from the single-crystal X-ray diffraction analysis were used as input files. The normalized contact distance (d<sub>norm</sub>) is defined in terms of functions of distance <italic toggle="yes">d<sub>i</sub></italic> and <italic toggle="yes">d<sub>e</sub></italic> and the van der Waals radii of the atoms. Once the surface has been calculated and the distance between the nearest nucleus inside the surface (<italic toggle="yes">d<sub>i</sub></italic>) and the nearest nucleus outside the surface (<italic toggle="yes">d<sub>e</sub></italic>) is lower, closer, or bigger than the sum of the van der Waals radii of them, the surface will indicate the presence or absence of contacts. Two-dimensional fingerprint plots were obtained with the combination of <italic toggle="yes">d<sub>i</sub></italic> and <italic toggle="yes">d<sub>e</sub></italic> distances, on the scale of 0.4 to 2.6 &#197;, to summarize the contacts present in the crystal structure of the complexes.</p></sec><sec id="sec3dot10-molecules-30-03516"><title>3.10. Anticancer Activity</title><sec id="sec3dot10dot1-molecules-30-03516"><title>3.10.1. Cell Culture</title><p>The cytotoxic activity of the synthesized compounds was evaluated against human cell lines, including breast cancer (MCF&#8211;7), cisplatin-resistant ovarian cancer (A2780cis), lung cancer (A549), and nontumor lung cells (MRC&#8211;5). The A549 and MRC-5 cell lines were cultured in Dulbecco&#8217;s Modified Eagle&#8217;s Medium (DMEM), while the MCF-7 and A2780cis cell lines were cultured in Roswell Park Memorial Institute (RPMI&#8211;1640). Both cultures were supplemented with 10% fetal bovine serum (FBS), penicillin (100 IU/mL), streptomycin (100 mg/mL), and L-glutamine (2 mM). The cells were grown as monolayers in disposable 25 cm<sup>2</sup> flasks and incubated at 37 &#176;C in a humidified atmosphere containing 5% CO<sub>2</sub>.</p></sec><sec id="sec3dot10dot2-molecules-30-03516"><title>3.10.2. Cell Viability Analysis</title><p>The cytotoxicity activity of the compounds was assessed using a colorimetric MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay [<xref rid="B48-molecules-30-03516" ref-type="bibr">48</xref>]. The cells were trypsinized, counted, and adjusted to the appropriate concentration and were seeded into 96-well plates at a density of 1.5 &#215; 10<sup>4</sup> cells/well. The plates were incubated at 37 &#176;C in a 5% CO<sub>2</sub> atmosphere for 24 h to allow cell adhesion. Subsequently, the compounds, solubilized in dimethyl sulfoxide (DMSO) at varying concentrations (200&#8212;1.56 &#181;M), were added to the wells, and the plates were incubated for 48 h. Cells treated with 0.5% DMSO served as the control. After the 48-h treatment period, 50 &#181;L of MTT solution (0.6 mg/mL in phosphate-buffered saline, PBS) was added to each well, followed by incubation for 4 h. The formazan crystals formed from the wells were separated from the solution and then solubilized by the addition of 100 &#181;L of DMSO per well. The absorbance was measured at 570 nm using a Varioskan LUX Multimode Microplate Reader (VL000D0, Waltham, MA 02451, USA). All experiments were performed in triplicate. The half-maximal inhibitory concentration (IC<sub>50</sub>) values were determined from dose&#8211;response curves using GraphPad Prism version 8 software [<xref rid="B48-molecules-30-03516" ref-type="bibr">48</xref>].</p></sec></sec></sec><sec sec-type="conclusions" id="sec4-molecules-30-03516"><title>4. Conclusions</title><p>Four new Ni(II) complexes with thiosemicarbazone and dithiocarbazate were successfully synthesized. The crystal structures were elucidated through single-crystal X-ray diffraction, which was consistent with the data obtained from spectroscopic and spectrometric analyses. All complexes exhibited a square planar geometry, with the ligands displaying double deprotonation and coordinated by tridentate mode through an <italic toggle="yes">ONS</italic> donor system. The coordination sphere was completed by a triphenylphosphine or pyridine coligand. Hirshfeld surface analysis was employed to estimate the topography of intermolecular interactions, while fingerprint plots provided quantitative insights into the most significant contributions to the crystal packing, primarily attributed to H&#8943;H and C&#8943;H interactions across all complexes. Biological assays show interesting results, particularly for the compounds containing pyridine as a substituent in their coordination sphere. Complex (<bold>2</bold>) exhibits potent cytotoxicity against breast and ovarian cancer cell lines compared to cisplatin; however, its lack of selectivity for nontumor cells raises concerns about its therapeutic potential. In contrast, complex (<bold>4</bold>) demonstrates a more promising profile, with moderate tumor cell inhibition and no observable toxicity to normal cells at concentrations up to 100 &#956;M, highlighting the importance of balancing efficacy and selectivity in the development of cancer treatments.</p></sec></body><back><ack><title>Acknowledgments</title><p>All funding agencies are acknowledged for their financial support.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-molecules-30-03516"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.mdpi.com/article/10.3390/molecules30173516/s1">https://www.mdpi.com/article/10.3390/molecules30173516/s1</uri>. Supplementary tables, figures, NMR, UV-vis, ESI(+)-MS, and IR spectra are as detailed in the text (PDF). Crystallographic data are in CIF files.</p><supplementary-material id="molecules-30-03516-s001" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-30-03516-s001.zip" position="float" orientation="portrait"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>G.S.P.: conceptualization; data curation; formal analysis; investigation; methodology; resources; validation. M.P.V.: conceptualization; data curation; formal analysis; investigation; methodology; resources; validation. K.M.O.: conceptualization; data curation; formal analysis; investigation; methodology; resources; validation. C.C.G.: conceptualization; data curation; formal analysis; funding acquisition; investigation; methodology; project administration; resources; software; supervision; validation. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The datasets generated for this study can be found in the <xref rid="app1-molecules-30-03516" ref-type="app">Supplementary Materials</xref>.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare that there were no conflicts of interest regarding the publication of this manuscript.</p></notes><ref-list><title>References</title><ref id="B1-molecules-30-03516"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edwards</surname><given-names>I.R.</given-names></name><name name-style="western"><surname>Aronson</surname><given-names>J.K.</given-names></name></person-group><article-title>Adverse Drug Reactions: Definitions, Diagnosis, and Management</article-title><source>Lancet</source><year>2000</year><volume>356</volume><fpage>1255</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(00)02799-9</pub-id><pub-id pub-id-type="pmid">11072960</pub-id></element-citation></ref><ref id="B2-molecules-30-03516"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Due</surname><given-names>A.</given-names></name></person-group><article-title>What Are Side Effects?</article-title><source>Eur. J. Philos. Sci.</source><year>2023</year><volume>13</volume><fpage>16</fpage><pub-id pub-id-type="doi">10.1007/s13194-023-00519-8</pub-id><pub-id pub-id-type="pmid">36936702</pub-id><pub-id pub-id-type="pmcid">PMC10006551</pub-id></element-citation></ref><ref id="B3-molecules-30-03516"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martinez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hemmert</surname><given-names>C.</given-names></name><name name-style="western"><surname>Loup</surname><given-names>C.</given-names></name><name name-style="western"><surname>Barr&#233;</surname><given-names>G.</given-names></name><name name-style="western"><surname>Meunier</surname><given-names>B.</given-names></name></person-group><article-title>Synthesis of New Macrocyclic Chiral Manganese(III) Schiff Bases as Catalysts for Asymmetric Epoxidation</article-title><source>J. Org. Chem.</source><year>2006</year><volume>71</volume><fpage>1449</fpage><lpage>1457</lpage><pub-id pub-id-type="doi">10.1021/jo052113c</pub-id><pub-id pub-id-type="pmid">16468793</pub-id></element-citation></ref><ref id="B4-molecules-30-03516"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berhanu</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Gaurav</surname></name><name name-style="western"><surname>Mohiuddin</surname><given-names>I.</given-names></name><name name-style="western"><surname>Malik</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Aulakh</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>K.-H.</given-names></name></person-group><article-title>A Review of the Applications of Schiff Bases as Optical Chemical Sensors</article-title><source>TrAC Trends Anal. Chem.</source><year>2019</year><volume>116</volume><fpage>74</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.trac.2019.04.025</pub-id></element-citation></ref><ref id="B5-molecules-30-03516"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Catalano</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sinicropi</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Iacopetta</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ceramella</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mariconda</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rosano</surname><given-names>C.</given-names></name><name name-style="western"><surname>Scali</surname><given-names>E.</given-names></name><name name-style="western"><surname>Saturnino</surname><given-names>C.</given-names></name><name name-style="western"><surname>Longo</surname><given-names>P.</given-names></name></person-group><article-title>A Review on the Advancements in the Field of Metal Complexes with Schiff Bases as Antiproliferative Agents</article-title><source>Appl. Sci.</source><year>2021</year><volume>11</volume><elocation-id>6027</elocation-id><pub-id pub-id-type="doi">10.3390/app11136027</pub-id></element-citation></ref><ref id="B6-molecules-30-03516"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ceramella</surname><given-names>J.</given-names></name><name name-style="western"><surname>Iacopetta</surname><given-names>D.</given-names></name><name name-style="western"><surname>Catalano</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cirillo</surname><given-names>F.</given-names></name><name name-style="western"><surname>Lappano</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sinicropi</surname><given-names>M.S.</given-names></name></person-group><article-title>A Review on the Antimicrobial Activity of Schiff Bases: Data Collection and Recent Studies</article-title><source>Antibiotics</source><year>2022</year><volume>11</volume><elocation-id>191</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics11020191</pub-id><pub-id pub-id-type="pmid">35203793</pub-id><pub-id pub-id-type="pmcid">PMC8868340</pub-id></element-citation></ref><ref id="B7-molecules-30-03516"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ejidike</surname><given-names>I.P.</given-names></name><name name-style="western"><surname>Ajibade</surname><given-names>P.A.</given-names></name></person-group><article-title>Transition Metal Complexes of Symmetrical and Asymmetrical Schiff Bases as Antibacterial, Antifungal, Antioxidant, and Anticancer Agents: Progress and Prospects</article-title><source>Rev. Inorg. Chem.</source><year>2015</year><volume>35</volume><fpage>191</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1515/revic-2015-0007</pub-id></element-citation></ref><ref id="B8-molecules-30-03516"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>W.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wen</surname><given-names>X.</given-names></name></person-group><article-title>Synthesis and Anticancer Activity of Thiosemicarbazones</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2006</year><volume>16</volume><fpage>2213</fpage><lpage>2218</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2006.01.048</pub-id><pub-id pub-id-type="pmid">16458509</pub-id></element-citation></ref><ref id="B9-molecules-30-03516"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heffeter</surname><given-names>P.</given-names></name><name name-style="western"><surname>Pape</surname><given-names>V.F.S.</given-names></name><name name-style="western"><surname>Enyedy</surname><given-names>&#201;.A.</given-names></name><name name-style="western"><surname>Keppler</surname><given-names>B.K.</given-names></name><name name-style="western"><surname>Szakacs</surname><given-names>G.</given-names></name><name name-style="western"><surname>Kowol</surname><given-names>C.R.</given-names></name></person-group><article-title>Anticancer Thiosemicarbazones: Chemical Properties, Interaction with Iron Metabolism, and Resistance Development</article-title><source>Antioxid. Redox Signal.</source><year>2019</year><volume>30</volume><fpage>1062</fpage><lpage>1082</lpage><pub-id pub-id-type="doi">10.1089/ars.2017.7487</pub-id><pub-id pub-id-type="pmid">29334758</pub-id></element-citation></ref><ref id="B10-molecules-30-03516"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>N.K.</given-names></name><name name-style="western"><surname>Kumbhar</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Pokharel</surname><given-names>Y.R.</given-names></name><name name-style="western"><surname>Yadav</surname><given-names>P.N.</given-names></name></person-group><article-title>Anticancer Potency of Copper(II) Complexes of Thiosemicarbazones</article-title><source>J. Inorg. Biochem.</source><year>2020</year><volume>210</volume><elocation-id>111134</elocation-id><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2020.111134</pub-id><pub-id pub-id-type="pmid">32673842</pub-id></element-citation></ref><ref id="B11-molecules-30-03516"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>E.L.</given-names></name><name name-style="western"><surname>Simmers</surname><given-names>C.</given-names></name><name name-style="western"><surname>Knight</surname><given-names>D.A.</given-names></name></person-group><article-title>Cobalt Complexes as Antiviral and Antibacterial Agents</article-title><source>Pharmaceuticals</source><year>2010</year><volume>3</volume><fpage>1711</fpage><lpage>1728</lpage><pub-id pub-id-type="doi">10.3390/ph3061711</pub-id><pub-id pub-id-type="pmid">27713325</pub-id><pub-id pub-id-type="pmcid">PMC4033948</pub-id></element-citation></ref><ref id="B12-molecules-30-03516"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Andrade Danin Barbosa</surname><given-names>G.</given-names></name><name name-style="western"><surname>Palermo de Aguiar</surname><given-names>A.</given-names></name></person-group><article-title>Synthesis of 1,3,4-Thiadiazole Derivatives and Microbiological Activities: A Review</article-title><source>Rev. Virtual Qu&#237;mica</source><year>2019</year><volume>11</volume><fpage>806</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.21577/1984-6835.20190058</pub-id></element-citation></ref><ref id="B13-molecules-30-03516"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gou</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fang</surname><given-names>G.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>G.</given-names></name></person-group><article-title>Dithiocarbazate-Copper Complexes for Bioimaging and Treatment of Pancreatic Cancer</article-title><source>J. Med. Chem.</source><year>2021</year><volume>64</volume><fpage>5485</fpage><lpage>5499</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.0c01936</pub-id><pub-id pub-id-type="pmid">33861929</pub-id></element-citation></ref><ref id="B14-molecules-30-03516"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gou</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>X.</given-names></name><name name-style="western"><surname>Hou</surname><given-names>L.X.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>H.W.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F.</given-names></name></person-group><article-title>Dithiocarbazate&#8211;Fe III, &#8211;Co III, &#8211;Ni II, and &#8211;Zn II Complexes: Design, Synthesis, Structure, and Anticancer Evaluation</article-title><source>J. Med. Chem.</source><year>2022</year><volume>65</volume><fpage>6677</fpage><lpage>6689</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.1c02186</pub-id><pub-id pub-id-type="pmid">35446587</pub-id></element-citation></ref><ref id="B15-molecules-30-03516"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leite</surname><given-names>T.S.O.</given-names></name><name name-style="western"><surname>Magalh&#227;es</surname><given-names>I.O.M.</given-names></name><name name-style="western"><surname>Machado</surname><given-names>D.F.S.</given-names></name><name name-style="western"><surname>Martins</surname><given-names>J.B.L.</given-names></name><name name-style="western"><surname>Gatto</surname><given-names>C.C.</given-names></name></person-group><article-title>Experimental and Theoretical Investigation of New Mono and Binuclear Cu(II) and Zn(II) Complexes with Dithiocarbazate Ligand</article-title><source>Struct. Chem.</source><year>2025</year><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1007/s11224-025-02494-7</pub-id></element-citation></ref><ref id="B16-molecules-30-03516"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nanjundan</surname><given-names>N.</given-names></name><name name-style="western"><surname>Selvakumar</surname><given-names>P.</given-names></name><name name-style="western"><surname>Narayanasamy</surname><given-names>R.</given-names></name><name name-style="western"><surname>Haque</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Velmurugan</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nandhakumar</surname><given-names>R.</given-names></name><name name-style="western"><surname>Silambarasan</surname><given-names>T.</given-names></name><name name-style="western"><surname>Dhandapani</surname><given-names>R.</given-names></name></person-group><article-title>Synthesis, Structure, DNA/BSA Interaction and in Vitro Cytotoxic Activity of Nickel(II) Complexes Derived from S-Allyldithiocarbazate</article-title><source>J. Photochem. Photobiol. B Biol.</source><year>2014</year><volume>141</volume><fpage>176</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/j.jphotobiol.2014.10.009</pub-id><pub-id pub-id-type="pmid">25463665</pub-id></element-citation></ref><ref id="B17-molecules-30-03516"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cavalcante</surname><given-names>C.d.Q.O.</given-names></name><name name-style="western"><surname>da Mota</surname><given-names>T.H.A.</given-names></name><name name-style="western"><surname>de Oliveira</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Nascimento</surname><given-names>&#201;.C.M.</given-names></name><name name-style="western"><surname>Martins</surname><given-names>J.B.L.</given-names></name><name name-style="western"><surname>Pittella-Silva</surname><given-names>F.</given-names></name><name name-style="western"><surname>Gatto</surname><given-names>C.C.</given-names></name></person-group><article-title>Dithiocarbazate Ligands and Their Ni(II) Complexes with Potential Biological Activity: Structural, Antitumor and Molecular Docking Study</article-title><source>Front. Mol. Biosci.</source><year>2023</year><volume>10</volume><fpage>6677</fpage><lpage>6689</lpage><pub-id pub-id-type="doi">10.3389/fmolb.2023.1146820</pub-id><pub-id pub-id-type="pmcid">PMC10034969</pub-id><pub-id pub-id-type="pmid">36968279</pub-id></element-citation></ref><ref id="B18-molecules-30-03516"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gatto</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Cavalcante</surname><given-names>C.d.Q.O.</given-names></name><name name-style="western"><surname>Lima</surname><given-names>F.C.</given-names></name><name name-style="western"><surname>Nascimento</surname><given-names>&#201;.C.M.</given-names></name><name name-style="western"><surname>Martins</surname><given-names>J.B.L.</given-names></name><name name-style="western"><surname>Santana</surname><given-names>B.L.O.</given-names></name><name name-style="western"><surname>Gualberto</surname><given-names>A.C.M.</given-names></name><name name-style="western"><surname>Pittella-Silva</surname><given-names>F.</given-names></name></person-group><article-title>Structural Design, Anticancer Evaluation, and Molecular Docking of Newly Synthesized Ni(II) Complexes with ONS-Donor Dithiocarbazate Ligands</article-title><source>Molecules</source><year>2024</year><volume>29</volume><elocation-id>2759</elocation-id><pub-id pub-id-type="doi">10.3390/molecules29122759</pub-id><pub-id pub-id-type="pmid">38930825</pub-id><pub-id pub-id-type="pmcid">PMC11206525</pub-id></element-citation></ref><ref id="B19-molecules-30-03516"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abd El-Lateef</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Khalaf</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Gouda</surname><given-names>M.</given-names></name><name name-style="western"><surname>Amer</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Abdelhamid</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Abdou</surname><given-names>A.</given-names></name></person-group><article-title>Synthesis, Characterization, and Therapeutic Potential of Novel Schiff Base Metal Complexes: Nickel(II) and Copper(II) Complexes Based 2-[(2-Chloroquinolin-3-yl)Methylidene]Aminobenzenethiol (CQAT)</article-title><source>Appl. Organomet. Chem.</source><year>2025</year><volume>39</volume><fpage>e7843</fpage><pub-id pub-id-type="doi">10.1002/aoc.7843</pub-id></element-citation></ref><ref id="B20-molecules-30-03516"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>&#214;zba&#287;c&#305;</surname><given-names>D.&#304;.</given-names></name><name name-style="western"><surname>Erda&#287;&#305;</surname><given-names>S.&#304;.</given-names></name><name name-style="western"><surname>Ayd&#305;n</surname><given-names>&#304;.</given-names></name><name name-style="western"><surname>Ayd&#305;n</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ar&#305;</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zorlu</surname><given-names>Y.</given-names></name></person-group><article-title>Crystal Structures and Biological Profiles of Novel Tridentate Schiff Bases Nickel (II) Complexes</article-title><source>Appl. Organomet. Chem.</source><year>2025</year><volume>39</volume><fpage>e7860</fpage><pub-id pub-id-type="doi">10.1002/aoc.7860</pub-id></element-citation></ref><ref id="B21-molecules-30-03516"><label>21.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Tewari</surname><given-names>B.B.</given-names></name></person-group><article-title>Metal Complexes in Biology and Medicine (Part- Mercury(II) / Nickel(II) /Lead(II)&#8211;Isoleucine)</article-title><source>Novel Aspects on Chemistry and Biochemistry</source><person-group person-group-type="editor"><name name-style="western"><surname>Mohamadpour</surname><given-names>D.F.</given-names></name></person-group><publisher-name>B P International (a part of SCIENCEDOMAIN International)</publisher-name><publisher-loc>Kolkata, India</publisher-loc><year>2023</year><volume>Volume 3</volume><fpage>111</fpage><lpage>127</lpage><isbn>9788119315451</isbn></element-citation></ref><ref id="B22-molecules-30-03516"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>B.</given-names></name><name name-style="western"><surname>Devi</surname><given-names>J.</given-names></name><name name-style="western"><surname>Dubey</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tufail</surname><given-names>A.</given-names></name><name name-style="western"><surname>Antil</surname><given-names>N.</given-names></name></person-group><article-title>Biological and Computational Investigation of Transition Metal(II) Complexes of 2-Phenoxyaniline-Based Ligands</article-title><source>Future Med. Chem.</source><year>2023</year><volume>15</volume><fpage>1919</fpage><lpage>1942</lpage><pub-id pub-id-type="doi">10.4155/fmc-2023-0046</pub-id><pub-id pub-id-type="pmid">37929611</pub-id></element-citation></ref><ref id="B23-molecules-30-03516"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Choudhary</surname><given-names>M.</given-names></name></person-group><article-title>An In Silico Design of Antivirus Nickel (II) Complexes as Therapeutic Drug Candidates</article-title><source>Indian J. Chem.</source><year>2023</year><volume>62</volume><fpage>586</fpage><lpage>599</lpage><pub-id pub-id-type="doi">10.56042/ijc.v62i6.2522</pub-id></element-citation></ref><ref id="B24-molecules-30-03516"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>B.N.</given-names></name><name name-style="western"><surname>Baecker</surname><given-names>D.</given-names></name><name name-style="western"><surname>Descher</surname><given-names>H.</given-names></name><name name-style="western"><surname>Brandstaetter</surname><given-names>P.</given-names></name><name name-style="western"><surname>Hermann</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kircher</surname><given-names>B.</given-names></name><name name-style="western"><surname>Gust</surname><given-names>R.</given-names></name></person-group><article-title>Synthesis and Biological Evaluation of Salophen Nickel(II) and Cobalt(III) Complexes as Potential Anticancer Compounds</article-title><source>Arch. Pharm.</source><year>2023</year><volume>356</volume><fpage>2200655</fpage><pub-id pub-id-type="doi">10.1002/ardp.202200655</pub-id><pub-id pub-id-type="pmid">36734178</pub-id></element-citation></ref><ref id="B25-molecules-30-03516"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abula</surname><given-names>A.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Aisa</surname><given-names>H.A.</given-names></name></person-group><article-title>Substitution Effect of the Trifluoromethyl Group on the Bioactivity in Medicinal Chemistry: Statistical Analysis and Energy Calculations</article-title><source>J. Chem. Inf. Model.</source><year>2020</year><volume>60</volume><fpage>6242</fpage><lpage>6250</lpage><pub-id pub-id-type="doi">10.1021/acs.jcim.0c00898</pub-id><pub-id pub-id-type="pmid">33258377</pub-id></element-citation></ref><ref id="B26-molecules-30-03516"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nov&#225;s</surname><given-names>M.</given-names></name><name name-style="western"><surname>Matos</surname><given-names>M.J.</given-names></name></person-group><article-title>The Role of Trifluoromethyl and Trifluoromethoxy Groups in Medicinal Chemistry: Implications for Drug Design</article-title><source>Molecules</source><year>2025</year><volume>30</volume><elocation-id>3009</elocation-id><pub-id pub-id-type="doi">10.3390/molecules30143009</pub-id><pub-id pub-id-type="pmid">40733275</pub-id><pub-id pub-id-type="pmcid">PMC12298972</pub-id></element-citation></ref><ref id="B27-molecules-30-03516"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Almeida</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Nascimento</surname><given-names>&#201;.C.M.</given-names></name><name name-style="western"><surname>Martins</surname><given-names>J.B.L.</given-names></name><name name-style="western"><surname>da Mota</surname><given-names>T.H.A.</given-names></name><name name-style="western"><surname>de Oliveira</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Gatto</surname><given-names>C.C.</given-names></name></person-group><article-title>Crystal Design, Antitumor Activity and Molecular Docking of Novel Palladium(II) and Gold(III) Complexes with a Thiosemicarbazone Ligand</article-title><source>Int. J. Mol. Sci.</source><year>2023</year><volume>24</volume><elocation-id>11442</elocation-id><pub-id pub-id-type="doi">10.3390/ijms241411442</pub-id><pub-id pub-id-type="pmid">37511201</pub-id><pub-id pub-id-type="pmcid">PMC10380234</pub-id></element-citation></ref><ref id="B28-molecules-30-03516"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Almeida</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Marcon</surname><given-names>P.H.S.</given-names></name><name name-style="western"><surname>Nascimento</surname><given-names>&#201;.C.M.</given-names></name><name name-style="western"><surname>Martins</surname><given-names>J.B.L.</given-names></name><name name-style="western"><surname>Chagas</surname><given-names>M.A.S.</given-names></name><name name-style="western"><surname>Fujimori</surname><given-names>M.</given-names></name><name name-style="western"><surname>De Marchi</surname><given-names>P.G.F.</given-names></name><name name-style="western"><surname>Fran&#231;a</surname><given-names>E.L.</given-names></name><name name-style="western"><surname>Honorio-Fran&#231;a</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Gatto</surname><given-names>C.C.</given-names></name></person-group><article-title>Organometallic Gold (III) and Platinum (II) Complexes with Thiosemicarbazone: Structural Behavior, Anticancer Activity, and Molecular Docking</article-title><source>Appl. Organomet. Chem.</source><year>2022</year><volume>36</volume><fpage>e6761</fpage><pub-id pub-id-type="doi">10.1002/aoc.6761</pub-id></element-citation></ref><ref id="B29-molecules-30-03516"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okuniewski</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rosiak</surname><given-names>D.</given-names></name><name name-style="western"><surname>Chojnacki</surname><given-names>J.</given-names></name><name name-style="western"><surname>Becker</surname><given-names>B.</given-names></name></person-group><article-title>Coordination Polymers and Molecular Structures among Complexes of Mercury(II) Halides with Selected 1-Benzoylthioureas</article-title><source>Polyhedron</source><year>2015</year><volume>90</volume><fpage>47</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.poly.2015.01.035</pub-id></element-citation></ref><ref id="B30-molecules-30-03516"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lima</surname><given-names>F.C.</given-names></name><name name-style="western"><surname>S&#243;</surname><given-names>Y.A.O.</given-names></name><name name-style="western"><surname>Gargano</surname><given-names>R.</given-names></name><name name-style="western"><surname>de Oliveira</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Gatto</surname><given-names>C.C.</given-names></name></person-group><article-title>Structural, Theoretical and Biological Activity of Mono and Binuclear Nickel(II) Complexes with Symmetrical and Asymmetrical 4,6-Diacetylresorcinol-Dithiocarbazate Ligands</article-title><source>J. Inorg. Biochem.</source><year>2021</year><volume>224</volume><elocation-id>111559</elocation-id><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2021.111559</pub-id><pub-id pub-id-type="pmid">34390890</pub-id></element-citation></ref><ref id="B31-molecules-30-03516"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Datta</surname><given-names>S.</given-names></name><name name-style="western"><surname>Seth</surname><given-names>D.K.</given-names></name><name name-style="western"><surname>Gangopadhyay</surname><given-names>S.</given-names></name><name name-style="western"><surname>Karmakar</surname><given-names>P.</given-names></name><name name-style="western"><surname>Bhattacharya</surname><given-names>S.</given-names></name></person-group><article-title>Nickel Complexes of Some Thiosemicarbazones: Synthesis, Structure, Catalytic Properties and Cytotoxicity Studies</article-title><source>Inorganica Chim. Acta</source><year>2012</year><volume>392</volume><fpage>118</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1016/j.ica.2012.05.034</pub-id></element-citation></ref><ref id="B32-molecules-30-03516"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Sousa</surname><given-names>G.F.</given-names></name><name name-style="western"><surname>Marques</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Resck</surname><given-names>I.S.</given-names></name><name name-style="western"><surname>Sabino</surname><given-names>J.R.</given-names></name></person-group><article-title>Synthesis and Crystal Structures of the Five-Coordinate Diorganotin(IV) Complex [Ph<sub>2</sub>Sn(L)]&#183;DMF and Its 5-Hydroxypyrazoline Ligand (H<sub>2</sub>L)</article-title><source>J. Chem. Crystallogr.</source><year>2011</year><volume>41</volume><fpage>528</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1007/s10870-010-9914-4</pub-id></element-citation></ref><ref id="B33-molecules-30-03516"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ali</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Mirza</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>Butcher</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Chowdhury</surname><given-names>A.K.</given-names></name></person-group><article-title>Synthesis, Spectroscopy, and X-Ray Crystal Structures of Copper(II) Complexes of the Tridentate ONS Ligand Formed by Condensation of 4,4,4-Trifluoro-1-(2-Thienyl)-2,4-Butanedione with S-Benzyldithiocarbazate</article-title><source>Transit. Met. Chem.</source><year>2011</year><volume>36</volume><fpage>471</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1007/s11243-011-9492-0</pub-id></element-citation></ref><ref id="B34-molecules-30-03516"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKinnon</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Spackman</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>A.S.</given-names></name></person-group><article-title>Novel Tools for Visualizing and Exploring Intermolecular Interactions in Molecular Crystals</article-title><source>Struct. Sci.</source><year>2004</year><volume>60</volume><fpage>627</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1107/S0108768104020300</pub-id><pub-id pub-id-type="pmid">15534375</pub-id></element-citation></ref><ref id="B35-molecules-30-03516"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spackman</surname><given-names>P.R.</given-names></name><name name-style="western"><surname>Turner</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>McKinnon</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Wolff</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Grimwood</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Jayatilaka</surname><given-names>D.</given-names></name><name name-style="western"><surname>Spackman</surname><given-names>M.A.</given-names></name></person-group><article-title>CrystalExplorer: A Program for Hirshfeld Surface Analysis, Visualization and Quantitative Analysis of Molecular Crystals</article-title><source>J. Appl. Crystallogr.</source><year>2021</year><volume>54</volume><fpage>1006</fpage><lpage>1011</lpage><pub-id pub-id-type="doi">10.1107/S1600576721002910</pub-id><pub-id pub-id-type="pmid">34188619</pub-id><pub-id pub-id-type="pmcid">PMC8202033</pub-id></element-citation></ref><ref id="B36-molecules-30-03516"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lakshmanan</surname><given-names>P.</given-names></name><name name-style="western"><surname>Gayathri</surname><given-names>E.</given-names></name><name name-style="western"><surname>Thirumaran</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ciattini</surname><given-names>S.</given-names></name></person-group><article-title>Synthesis, Crystal Structure, DFT and Hirshfeld Surface Analysis of Ni(II) Complexes: Precursor for Nickel Sulfide Nanoparticles</article-title><source>J. Mol. Struct.</source><year>2023</year><volume>1273</volume><fpage>134306</fpage><pub-id pub-id-type="doi">10.1016/j.molstruc.2022.134306</pub-id></element-citation></ref><ref id="B37-molecules-30-03516"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hussain Dar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hasan</surname><given-names>N.</given-names></name><name name-style="western"><surname>Rana</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fatima</surname><given-names>A.</given-names></name><name name-style="western"><surname>Noorul Sabah Andrabi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ahmedi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Manzoor</surname><given-names>N.</given-names></name><name name-style="western"><surname>Javed</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rahisuddin</surname></name></person-group><article-title>Synthesis and Spectral Studies of Ni(II) Complexes Involving Functionalized Dithiocarbamates and Triphenylphosphine: X-Ray Crystal Structure, Thermal Stability, Hirshfeld Surface Analysis, DFT and Biological Evaluation</article-title><source>Inorganica Chim. Acta</source><year>2023</year><volume>545</volume><fpage>121271</fpage><pub-id pub-id-type="doi">10.1016/j.ica.2022.121271</pub-id></element-citation></ref><ref id="B38-molecules-30-03516"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Almeida</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>de Carvalho</surname><given-names>J.G.M.</given-names></name><name name-style="western"><surname>Fujimori</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fran&#231;a</surname><given-names>E.L.</given-names></name><name name-style="western"><surname>Honorio-Fran&#231;a</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Parreira</surname><given-names>R.L.T.</given-names></name><name name-style="western"><surname>Orenha</surname><given-names>R.P.</given-names></name><name name-style="western"><surname>Gatto</surname><given-names>C.C.</given-names></name></person-group><article-title>Structural Investigation of Group 10 Metal Complexes with Thiosemicarbazone: Crystal Structure, Mass Spectrometry, Hirshfeld Surface and in Vitro Antitumor Activity</article-title><source>Struct. Chem.</source><year>2020</year><volume>31</volume><fpage>2093</fpage><lpage>2103</lpage><pub-id pub-id-type="doi">10.1007/s11224-020-01564-2</pub-id></element-citation></ref><ref id="B39-molecules-30-03516"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lima</surname><given-names>D.J.B.</given-names></name><name name-style="western"><surname>Almeida</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Jardim</surname><given-names>G.A.M.</given-names></name><name name-style="western"><surname>Barbosa</surname><given-names>B.P.A.</given-names></name><name name-style="western"><surname>Santos</surname><given-names>A.C.C.</given-names></name><name name-style="western"><surname>Valen&#231;a</surname><given-names>W.O.</given-names></name><name name-style="western"><surname>Scheide</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Gatto</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>de Carvalho</surname><given-names>G.G.C.</given-names></name><name name-style="western"><surname>Costa</surname><given-names>P.M.S.</given-names></name><etal/></person-group><article-title>It Takes Two to Tango: Synthesis of Cytotoxic Quinones Containing Two Redox Active Centers with Potential Antitumor Activity</article-title><source>RSC Med. Chem.</source><year>2021</year><volume>12</volume><fpage>1709</fpage><lpage>1721</lpage><pub-id pub-id-type="doi">10.1039/D1MD00168J</pub-id><pub-id pub-id-type="pmid">34778772</pub-id><pub-id pub-id-type="pmcid">PMC8528272</pub-id></element-citation></ref><ref id="B40-molecules-30-03516"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leovac</surname><given-names>V.M.</given-names></name><name name-style="western"><surname>&#268;e&#353;ljevi&#263;</surname><given-names>V.I.</given-names></name><name name-style="western"><surname>Ne&#353;i&#263;</surname><given-names>S.M.</given-names></name></person-group><article-title>Transition Metal Complexes with the Thiosemicarbazide-based Ligands. XII. Complexes of Nickel(II) with Benzoylacetone S-methylisothiosemicarbazone and N(1)-2-butylidene-4-oxo-4-phenyl-N(4)-salicylidene-S-methylisothiosemicarbazide</article-title><source>Zeitschrift f&#252;r Anorg. und Allg. Chemie</source><year>1991</year><volume>592</volume><fpage>217</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1002/zaac.19915920122</pub-id></element-citation></ref><ref id="B41-molecules-30-03516"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Almeida</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Nascimento</surname><given-names>G.P.</given-names></name><name name-style="western"><surname>Magalh&#227;es</surname><given-names>K.G.</given-names></name><name name-style="western"><surname>Iglesias</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Gatto</surname><given-names>C.C.</given-names></name></person-group><article-title>Crystal Structures, DNA-Binding Ability and Influence on Cellular Viability of Gold(I) Complexes of Thiosemicarbazones</article-title><source>J. Coord. Chem.</source><year>2018</year><volume>71</volume><fpage>502</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1080/00958972.2018.1435869</pub-id></element-citation></ref><ref id="B42-molecules-30-03516"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cavalcante</surname><given-names>C.D.Q.O.</given-names></name><name name-style="western"><surname>Arcanjo</surname><given-names>D.D.S.</given-names></name><name name-style="western"><surname>Silva</surname><given-names>G.G.D.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>D.M.D.</given-names></name><name name-style="western"><surname>Gatto</surname><given-names>C.C.</given-names></name></person-group><article-title>Solution and Solid Behavior of Mono and Binuclear Zinc(Ii) and Nickel(Ii) Complexes with Dithiocarbazates: X-Ray Analysis, Mass Spectrometry and Cytotoxicity against Cancer Cell Lines</article-title><source>New J. Chem.</source><year>2019</year><volume>43</volume><fpage>11209</fpage><lpage>11221</lpage><pub-id pub-id-type="doi">10.1039/C9NJ01814J</pub-id></element-citation></ref><ref id="B43-molecules-30-03516"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lima</surname><given-names>F.C.</given-names></name><name name-style="western"><surname>Silva</surname><given-names>T.S.</given-names></name><name name-style="western"><surname>Martins</surname><given-names>C.H.G.</given-names></name><name name-style="western"><surname>Gatto</surname><given-names>C.C.</given-names></name></person-group><article-title>Synthesis, Crystal Structures and Antimicrobial Activity of Dimeric Copper(II) Complexes with 2-Hydroxyphenyl-Ethylidene-Dithiocarbazates</article-title><source>Inorganica Chim. Acta</source><year>2018</year><volume>483</volume><fpage>464</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1016/j.ica.2018.08.032</pub-id></element-citation></ref><ref id="B44-molecules-30-03516"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haas</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lieb</surname><given-names>M.</given-names></name><name name-style="western"><surname>Schelvis</surname><given-names>M.</given-names></name></person-group><article-title>Trifluoromethyl-Substituted Heteroolefins (Schiffs Bases): Syntheses and Chemical Properties</article-title><source>J. Fluor. Chem.</source><year>1997</year><volume>83</volume><fpage>133</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1016/S0022-1139(97)00017-1</pub-id></element-citation></ref><ref id="B45-molecules-30-03516"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colmenares</surname><given-names>L.U.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>R.S.H.</given-names></name></person-group><article-title><sup>1</sup>H NMR and <sup>19</sup>F NMR Chemical Shifts of Fluorinated Retinals, Schiff Bases and Protonated Schiff Bases</article-title><source>Magn. Reson. Chem.</source><year>1992</year><volume>30</volume><fpage>490</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1002/mrc.1260300606</pub-id></element-citation></ref><ref id="B46-molecules-30-03516"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gokulnath</surname><given-names>G.</given-names></name><name name-style="western"><surname>Manikandan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Anitha</surname><given-names>P.</given-names></name><name name-style="western"><surname>Umarani</surname><given-names>C.</given-names></name></person-group><article-title>Synthesis, characterization and antibacterial studies of CO(II), NI(II) and CU(II) complexes containing triphenylphosphine and schiff base ligand based on salicylaldehyde</article-title><source>Rasayan J. Chem.</source><year>2022</year><volume>14</volume><fpage>2692</fpage><lpage>2697</lpage><pub-id pub-id-type="doi">10.31788/RJC.2021.1446480</pub-id></element-citation></ref><ref id="B47-molecules-30-03516"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muthu Tamizh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mereiter</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kirchner</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ramachandra Bhat</surname><given-names>B.</given-names></name><name name-style="western"><surname>Karvembu</surname><given-names>R.</given-names></name></person-group><article-title>Synthesis, Crystal Structures and Spectral Studies of Square Planar Nickel(II) Complexes Containing an ONS Donor Schiff Base and Triphenylphosphine</article-title><source>Polyhedron</source><year>2009</year><volume>28</volume><fpage>2157</fpage><lpage>2164</lpage><pub-id pub-id-type="doi">10.1016/j.poly.2009.04.021</pub-id></element-citation></ref><ref id="B48-molecules-30-03516"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mosmann</surname><given-names>T.</given-names></name></person-group><article-title>Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays</article-title><source>J. Immunol. Methods</source><year>1983</year><volume>65</volume><fpage>55</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/0022-1759(83)90303-4</pub-id><pub-id pub-id-type="pmid">6606682</pub-id></element-citation></ref><ref id="B49-molecules-30-03516"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ni</surname><given-names>M.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Dai</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Z.</given-names></name></person-group><article-title>Molecular Mechanisms of Cisplatin Resistance in Ovarian Cancer</article-title><source>Genes Dis.</source><year>2024</year><volume>11</volume><fpage>101063</fpage><pub-id pub-id-type="doi">10.1016/j.gendis.2023.06.032</pub-id><pub-id pub-id-type="pmid">39224110</pub-id><pub-id pub-id-type="pmcid">PMC11367050</pub-id></element-citation></ref><ref id="B50-molecules-30-03516"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>West</surname><given-names>D.X.</given-names></name><name name-style="western"><surname>Ives</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Bain</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Liberta</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Vald&#233;s-Mart&#237;nez</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ebert</surname><given-names>K.H.</given-names></name><name name-style="western"><surname>Hern&#225;ndez-Ortega</surname><given-names>S.</given-names></name></person-group><article-title>Copper(II) and Nickel(II) Complexes of 2,3-Butanedione Bis(N(3)-Substituted Thiosemicarbazones)</article-title><source>Polyhedron</source><year>1997</year><volume>16</volume><fpage>1895</fpage><lpage>1905</lpage><pub-id pub-id-type="doi">10.1016/S0277-5387(96)00468-8</pub-id></element-citation></ref><ref id="B51-molecules-30-03516"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akbar Ali</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tarafdar</surname><given-names>M.T.H.</given-names></name></person-group><article-title>Metal Complexes of Sulphur and Nitrogen-Containing Ligands: Complexes of s-Benzyldithiocarbazate and a Schiff Base Formed by Its Condensation with Pyridine-2-Carboxaldehyde</article-title><source>J. Inorg. Nucl. Chem.</source><year>1977</year><volume>39</volume><fpage>1785</fpage><lpage>1791</lpage><pub-id pub-id-type="doi">10.1016/0022-1902(77)80202-9</pub-id></element-citation></ref><ref id="B52-molecules-30-03516"><label>52.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>SMART and SAINT</surname></name></person-group><source>Area Detector Control Integration Software</source><publisher-name>Bruker AXS</publisher-name><publisher-loc>Karlsruhe, Germany</publisher-loc><year>1999</year></element-citation></ref><ref id="B53-molecules-30-03516"><label>53.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Sheldrick</surname><given-names>G.M.</given-names></name></person-group><source>SADABS, Program for Empirical Absorption Correction of Area Detector Data</source><publisher-name>University of G&#246;ttingen</publisher-name><publisher-loc>G&#246;ttingen, Germany</publisher-loc><year>1997</year></element-citation></ref><ref id="B54-molecules-30-03516"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sheldrick</surname><given-names>G.M.</given-names></name></person-group><article-title>A Short History of SHELX</article-title><source>Acta Crystallogr. Sect. A</source><year>2008</year><volume>64</volume><fpage>112</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1107/S0108767307043930</pub-id><pub-id pub-id-type="pmid">18156677</pub-id></element-citation></ref><ref id="B55-molecules-30-03516"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sheldrick</surname><given-names>G.M.</given-names></name></person-group><article-title>Crystal Structure Refinement with SHELXL</article-title><source>Acta Crystallogr. Sect. C</source><year>2015</year><volume>71</volume><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1107/S2053229614024218</pub-id><pub-id pub-id-type="pmid">25567568</pub-id><pub-id pub-id-type="pmcid">PMC4294323</pub-id></element-citation></ref><ref id="B56-molecules-30-03516"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dolomanov</surname><given-names>O.V.</given-names></name><name name-style="western"><surname>Bourhis</surname><given-names>L.J.</given-names></name><name name-style="western"><surname>Gildea</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Howard</surname><given-names>J.A.K.</given-names></name><name name-style="western"><surname>Puschmann</surname><given-names>H.</given-names></name></person-group><article-title>OLEX2: A Complete Structure Solution, Refinement and Analysis Program</article-title><source>J. Appl. Crystallogr.</source><year>2009</year><volume>42</volume><fpage>339</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1107/S0021889808042726</pub-id></element-citation></ref><ref id="B57-molecules-30-03516"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>MacRae</surname><given-names>C.F.</given-names></name><name name-style="western"><surname>Sovago</surname><given-names>I.</given-names></name><name name-style="western"><surname>Cottrell</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Galek</surname><given-names>P.T.A.</given-names></name><name name-style="western"><surname>McCabe</surname><given-names>P.</given-names></name><name name-style="western"><surname>Pidcock</surname><given-names>E.</given-names></name><name name-style="western"><surname>Platings</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shields</surname><given-names>G.P.</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Towler</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Mercury 4.0: From Visualization to Analysis, Design and Prediction</article-title><source>J. Appl. Crystallogr.</source><year>2020</year><volume>53</volume><fpage>226</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1107/S1600576719014092</pub-id><pub-id pub-id-type="pmid">32047413</pub-id><pub-id pub-id-type="pmcid">PMC6998782</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="molecules-30-03516-f001" orientation="portrait"><label>Figure 1</label><caption><p>General structures of a thiosemicarbazone (TSC) and a dithiocarbazate (DTC); R = alkyl or aryl groups.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03516-g001.jpg"/></fig><fig position="float" id="molecules-30-03516-f002" orientation="portrait"><label>Figure 2</label><caption><p>Synthesis of the complexes (<bold>1</bold>&#8211;<bold>4</bold>) obtained from the reactions between Ni(II), coligands (PPh<sub>3</sub> or Py), and the ligands H<sub>2</sub>L<sup>1</sup> and H<sub>2</sub>L<sup>2</sup>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03516-g002.jpg"/></fig><fig position="float" id="molecules-30-03516-f003" orientation="portrait"><label>Figure 3</label><caption><p>Molecular structures of the complexes (<bold>1</bold>&#8211;<bold>4</bold>) with crystallographic labeling. Thermal ellipsoids with 30% probability.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03516-g003.jpg"/></fig><fig position="float" id="molecules-30-03516-f004" orientation="portrait"><label>Figure 4</label><caption><p>Hirshfeld surface in the d<sub>norm</sub> function and a full two-dimensional fingerprint plot showing the non-covalent interactions for the complexes (<bold>1</bold>&#8211;<bold>4</bold>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03516-g004.jpg"/></fig><fig position="float" id="molecules-30-03516-f005" orientation="portrait"><label>Figure 5</label><caption><p>Percentage contribution of close contacts of the complexes (<bold>1</bold>&#8211;<bold>4</bold>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03516-g005.jpg"/></fig><fig position="float" id="molecules-30-03516-f006" orientation="portrait"><label>Figure 6</label><caption><p>ESI(+)&#8211;MS/MS spectrum of the complex (<bold>1</bold>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03516-g006.jpg"/></fig><fig position="float" id="molecules-30-03516-f007" orientation="portrait"><label>Figure 7</label><caption><p>ESI(+)&#8211;MS/MS spectrum of the complex (<bold>4</bold>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03516-g007.jpg"/></fig><fig position="float" id="molecules-30-03516-f008" orientation="portrait"><label>Figure 8</label><caption><p>Evaluation of cytotoxic effects by MTT assay in 48 h. DMSO at 0.5% did not affect the cell viability of the cell lines.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03516-g008.jpg"/></fig><table-wrap position="float" id="molecules-30-03516-t001" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03516-t001_Table 1</object-id><label>Table 1</label><caption><p>Selected bond lengths (&#197;) and bond angles (&#176;) for the complexes (<bold>1</bold>&#8211;<bold>4</bold>).</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="5" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Bond Lengths (&#197;)</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(1)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(2)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(3)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(4)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">C5&#8211;O1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.295(4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.280(11)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.297(4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.299(7)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C7&#8211;N1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.324(4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.312(10)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.321(5)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.325(7)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">N1&#8211;N2</td><td align="center" valign="middle" rowspan="1" colspan="1">1.392(3)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.408(10)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.396(4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.406(5)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">N2&#8211;C9</td><td align="center" valign="middle" rowspan="1" colspan="1">1.293(4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.309(11)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.291(5)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.292(7)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C9&#8211;S2</td><td align="center" valign="middle" rowspan="1" colspan="1">1.732(3)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.745(9)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.732(4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.735(6)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ni1&#8211;O1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.841(2)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.857(6)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.849(3)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.835(4)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ni1&#8211;N1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.898(3)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.863(7)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.874(3)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.859(4)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ni1&#8211;S2</td><td align="center" valign="middle" rowspan="1" colspan="1">2.112(10)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.143(3)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.137(12)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.128(16)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ni1&#8211;PPh<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">2.204(10)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">2.210(12)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ni&#8211;Py</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">1.919(8)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">1.903(5)</td></tr><tr><td colspan="5" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">
<bold>Bond Angles (&#176;)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>(1)</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>(2)</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>(3)</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>(4)</bold>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">N1&#8211;Ni1&#8211;S2</td><td align="center" valign="middle" rowspan="1" colspan="1">87.28(8)</td><td align="center" valign="middle" rowspan="1" colspan="1">86.7(2)</td><td align="center" valign="middle" rowspan="1" colspan="1">87.46(10)</td><td align="center" valign="middle" rowspan="1" colspan="1">88.04(14)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">O1&#8211;Ni1&#8211;N1</td><td align="center" valign="middle" rowspan="1" colspan="1">95.98(10)</td><td align="center" valign="middle" rowspan="1" colspan="1">95.6(3)</td><td align="center" valign="middle" rowspan="1" colspan="1">93.99(13)</td><td align="center" valign="middle" rowspan="1" colspan="1">95.82(19)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">O1&#8211;Ni&#8211;S2</td><td align="center" valign="middle" rowspan="1" colspan="1">175.94(8)</td><td align="center" valign="middle" rowspan="1" colspan="1">177.6(19)</td><td align="center" valign="middle" rowspan="1" colspan="1">174.23(10)</td><td align="center" valign="middle" rowspan="1" colspan="1">175.39(14)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">O1&#8211;Ni1&#8211;PPh<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">85.87(7)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">86.50(9)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">S2&#8211;Ni1&#8211;PPh<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">90.85(4)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">92.24(5)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">N1&#8211;Ni1&#8211;PPh<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">178.12(8)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">178.07(10)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">O1&#8211;Ni1&#8211;Py</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">86.7(3)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">86.11(18)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">S2&#8211;Ni1&#8211;Py</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">91.0(2)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">90.00(13)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N1&#8211;Ni1&#8211;Py</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">174.6(3)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">177.96(19)</td></tr></tbody></table></table-wrap><table-wrap position="float" id="molecules-30-03516-t002" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03516-t002_Table 2</object-id><label>Table 2</label><caption><p>Angular strain and strain (cm<sup>&#8722;1</sup>) frequencies of the normal vibration modes selected for H<sub>2</sub>L<sup>1</sup>, H<sub>2</sub>L<sup>2</sup>, and the complexes (<bold>1</bold>&#8211;<bold>4</bold>).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">H<sub>2</sub>L<sup>1</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">H<sub>2</sub>L<sup>2</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">(1)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">(2)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">(3)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">(4)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#957;(C=S)</td><td align="center" valign="middle" rowspan="1" colspan="1">1307</td><td align="center" valign="middle" rowspan="1" colspan="1">1306</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#957;(C&#8211;S)</td><td align="center" valign="middle" rowspan="1" colspan="1">728</td><td align="center" valign="middle" rowspan="1" colspan="1">732</td><td align="center" valign="middle" rowspan="1" colspan="1">746</td><td align="center" valign="middle" rowspan="1" colspan="1">746</td><td align="center" valign="middle" rowspan="1" colspan="1">746</td><td align="center" valign="middle" rowspan="1" colspan="1">759</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#957;(N&#8211;N)</td><td align="center" valign="middle" rowspan="1" colspan="1">1038</td><td align="center" valign="middle" rowspan="1" colspan="1">1064</td><td align="center" valign="middle" rowspan="1" colspan="1">1097</td><td align="center" valign="middle" rowspan="1" colspan="1">1066</td><td align="center" valign="middle" rowspan="1" colspan="1">1095</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#957;(C=O)</td><td align="center" valign="middle" rowspan="1" colspan="1">1651</td><td align="center" valign="middle" rowspan="1" colspan="1">1637</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#957;(C=N)</td><td align="center" valign="middle" rowspan="1" colspan="1">1597</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">1544</td><td align="center" valign="middle" rowspan="1" colspan="1">1544</td><td align="center" valign="middle" rowspan="1" colspan="1">1544</td><td align="center" valign="middle" rowspan="1" colspan="1">1544</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#957;(N&#8211;H)</td><td align="center" valign="middle" rowspan="1" colspan="1">3333/3304</td><td align="center" valign="middle" rowspan="1" colspan="1">3195</td><td align="center" valign="middle" rowspan="1" colspan="1">3401</td><td align="center" valign="middle" rowspan="1" colspan="1">3343</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#948;(Py)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">690</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">694</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#957;(Ni&#8211;PPh<sub>3</sub>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">692</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">692</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8211;</td></tr></tbody></table></table-wrap><table-wrap position="float" id="molecules-30-03516-t003" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03516-t003_Table 3</object-id><label>Table 3</label><caption><p>Absorption values of the ligands and complexes (<bold>1</bold>&#8211;<bold>4</bold>).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&#960;&#8211;&#960;*</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Log &#949;</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">n&#8211;&#960;*</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Log &#949;</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">LMCT</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Log &#949;</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">H<sub>2</sub>L<sup>1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">MeOH</td><td align="center" valign="middle" rowspan="1" colspan="1">284</td><td align="center" valign="middle" rowspan="1" colspan="1">4.09</td><td align="center" valign="middle" rowspan="1" colspan="1">415</td><td align="center" valign="middle" rowspan="1" colspan="1">3.59</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">DMF</td><td align="center" valign="middle" rowspan="1" colspan="1">283</td><td align="center" valign="middle" rowspan="1" colspan="1">4.26</td><td align="center" valign="middle" rowspan="1" colspan="1">431</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">H<sub>2</sub>L<sup>2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">MeOH</td><td align="center" valign="middle" rowspan="1" colspan="1">262 and 295</td><td align="center" valign="middle" rowspan="1" colspan="1">4.03 and 4.10</td><td align="center" valign="middle" rowspan="1" colspan="1">445</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">DMF</td><td align="center" valign="middle" rowspan="1" colspan="1">294</td><td align="center" valign="middle" rowspan="1" colspan="1">4.19</td><td align="center" valign="middle" rowspan="1" colspan="1">451</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>1</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">MeOH</td><td align="center" valign="middle" rowspan="1" colspan="1">230 and 273</td><td align="center" valign="middle" rowspan="1" colspan="1">4.13 and 4.14</td><td align="center" valign="middle" rowspan="1" colspan="1">441</td><td align="center" valign="middle" rowspan="1" colspan="1">3.88</td><td align="center" valign="middle" rowspan="1" colspan="1">461 and 490</td><td align="center" valign="middle" rowspan="1" colspan="1">3.87 and 3.79</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">DMF</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">445</td><td align="center" valign="middle" rowspan="1" colspan="1">4.36</td><td align="center" valign="middle" rowspan="1" colspan="1">465 and 498</td><td align="center" valign="middle" rowspan="1" colspan="1">4.34 and 4.25</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>2</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">MeOH</td><td align="center" valign="middle" rowspan="1" colspan="1">257</td><td align="center" valign="middle" rowspan="1" colspan="1">4.24</td><td align="center" valign="middle" rowspan="1" colspan="1">336</td><td align="center" valign="middle" rowspan="1" colspan="1">3.89</td><td align="center" valign="middle" rowspan="1" colspan="1">462 and 493</td><td align="center" valign="middle" rowspan="1" colspan="1">3.87 and 3.70</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">DMF</td><td align="center" valign="middle" rowspan="1" colspan="1">279</td><td align="center" valign="middle" rowspan="1" colspan="1">4.24</td><td align="center" valign="middle" rowspan="1" colspan="1">446</td><td align="center" valign="middle" rowspan="1" colspan="1">4.15</td><td align="center" valign="middle" rowspan="1" colspan="1">468 and 497</td><td align="center" valign="middle" rowspan="1" colspan="1">4.13 and 4.04</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>3</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">MeOH</td><td align="center" valign="middle" rowspan="1" colspan="1">254 and 275</td><td align="center" valign="middle" rowspan="1" colspan="1">4.18 and 4.16</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">449</td><td align="center" valign="middle" rowspan="1" colspan="1">4.08</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">DMF</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" rowspan="1" colspan="1">455</td><td align="center" valign="middle" rowspan="1" colspan="1">4.29</td><td align="center" valign="middle" rowspan="1" colspan="1">488</td><td align="center" valign="middle" rowspan="1" colspan="1">4.10</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>4</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">MeOH</td><td align="center" valign="middle" rowspan="1" colspan="1">257</td><td align="center" valign="middle" rowspan="1" colspan="1">4.18</td><td align="center" valign="middle" rowspan="1" colspan="1">301</td><td align="center" valign="middle" rowspan="1" colspan="1">3.97</td><td align="center" valign="middle" rowspan="1" colspan="1">454</td><td align="center" valign="middle" rowspan="1" colspan="1">4.10</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DMF</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">455</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.35</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">488</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.16</td></tr></tbody></table></table-wrap><table-wrap position="float" id="molecules-30-03516-t004" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03516-t004_Table 4</object-id><label>Table 4</label><caption><p><sup>1</sup>H, <sup>19</sup>F, and <sup>31</sup>P NMR spectral data of the ligands H<sub>2</sub>L<sup>1</sup> and H<sub>2</sub>L<sup>2</sup> and the complexes (<bold>1</bold>&#8211;<bold>4</bold>).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><sup>1</sup>H (ppm)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><sup>19</sup>F (ppm)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><sup>31</sup>P (ppm)</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H<sub>2</sub>L<sup>1</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.72 (s, 1H, N&#8211;H), 10.19 (s, 1H, N&#8211;H), 8.12&#8211;8.10 (m, 1H, &#8211;CH), 8.10&#8211;8.08 (m, 1H, &#8211;CH), 7.53 (d, J = 7.20 Hz, 1H, Ar), 7.39 (dd, J = 7.40 and 7.20 Hz, 1H, Ar), 7.33 (dd, J = 3.89 and 3.74 Hz, 1H, Ar), 7.25 (t, J = 7.40 Hz, 1H, Ar), 4.67 (s, 2H, CH<sub>2</sub>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8722;67.57 (s, CF<sub>3</sub>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8722;6.50 (s, PPh<sub>3</sub>-free)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H<sub>2</sub>L<sup>2</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.20 (s, 1H, N&#8211;H), 8.10 (m, J = 4.92 Hz, 1H, &#8211;CH), 8.07 (m, J = 3.80 Hz, 1H, &#8211;CH), 7.42 (d, J = 7.50 Hz, 1H, Ar), 7.36&#8211;7.27 (m, 4H, Ar), 4.65 (s, 2H, &#8211;CH<sub>2</sub>), 4.46 (s, 2H, CH<sub>2</sub>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8722;68.40 (s, CF<sub>3</sub>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8722;6.50 (s, PPh<sub>3</sub>-free)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(<bold>1</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.40 (s, 1H, N&#8211;H), 7.78 (t, 6H, PPh3), 7.64&#8211;7.51 (m, 13H, Ar and PPh3), 7.20 (t, 2H, Ar), 6.92&#8211;6.89 (m, 1H, &#8211;CH), 6.87 (t, J = 7.35 Hz, 1H, Ar), 6.26 (s, 1H, &#8211;CH)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8722;63.63 (s, CF<sub>3</sub>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.92 (s, PPh<sub>3</sub>)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(<bold>2</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.40 (s, 1H, N&#8211;H), 9.06 (s, 2H, &#8211;CH Py), 8.04 (s, 1H, &#8211;CH Py), 7.72&#8211;7.51 (m, 6H, Ar and Py), 7.21 (t, J = 7.31 Hz, 2H, Ar), 7.14&#8211;7.07 (m, 1H, &#8211;CH), 6.88 (t, J = 7.31 Hz, 1H, Ar), 6.17 (s, 1H, &#8211;CH)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8722;63.13 (s, CF<sub>3</sub>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(<bold>3</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.80&#8211;7.65 (m, 6H, PPh3), 7.65&#8211;7.42 (m, 13H, Ar and PPh3), 7.34&#8211;7.29 (m, 4H, Ar), 7.29&#8211;7.22 (m, 1H, Ar), 4.33 (s, 2H, &#8211;CH<sub>2</sub>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8722;62.04 (s, CF<sub>3</sub>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.30 (s, PPh<sub>3</sub>)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(<bold>4</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.39 (s, 2H, Py), 8.16&#8211;7.79 (m, 13H, Ar and Py), 7.46&#8211;7.37 (m, 1H, Ar), 7.37&#8211;7.26 (m, 4H, Ar), 7.26&#8211;7.15 (m, 1H, Ar), 4.10 (s, 2H, &#8211;CH<sub>2</sub>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8722;62.33 (s, CF<sub>3</sub>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8211;</td></tr></tbody></table></table-wrap><table-wrap position="float" id="molecules-30-03516-t005" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03516-t005_Table 5</object-id><label>Table 5</label><caption><p>Cytotoxic activity of H<sub>2</sub>L<sup>1</sup>, H<sub>2</sub>L<sup>2</sup>, and the complexes (<bold>1</bold>&#8211;<bold>4</bold>). Results are presented as IC<sub>50</sub> values (&#181;M) &#177; SD in 48 h (values estimated by non-linear regression of data from viability assessment).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Compounds</th><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">IC<sub>50</sub> (&#181;M)</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A2780cis</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A549</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MRC-5</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">H<sub>2</sub>L<sup>1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">&gt;100</td><td align="center" valign="middle" rowspan="1" colspan="1">(42.78 &#177; 0.66)</td><td align="center" valign="middle" rowspan="1" colspan="1">(51.38 &#177; 4.37)</td><td align="center" valign="middle" rowspan="1" colspan="1">&gt;100</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">H<sub>2</sub>L<sup>2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">&gt;100</td><td align="center" valign="middle" rowspan="1" colspan="1">(78.93 &#177; 1.96)</td><td align="center" valign="middle" rowspan="1" colspan="1">&gt;100</td><td align="center" valign="middle" rowspan="1" colspan="1">&gt;100</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>1</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">&gt;100</td><td align="center" valign="middle" rowspan="1" colspan="1">&gt;100</td><td align="center" valign="middle" rowspan="1" colspan="1">&gt;100</td><td align="center" valign="middle" rowspan="1" colspan="1">&gt;100</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>2</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">(8.48 &#177; 1.37)</td><td align="center" valign="middle" rowspan="1" colspan="1">(7.20 &#177; 0.73)</td><td align="center" valign="middle" rowspan="1" colspan="1">(27.18 &#177; 2.91)</td><td align="center" valign="middle" rowspan="1" colspan="1">(9.89 &#177; 0.17)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>3</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">&gt;100</td><td align="center" valign="middle" rowspan="1" colspan="1">&gt;100</td><td align="center" valign="middle" rowspan="1" colspan="1">&gt;100</td><td align="center" valign="middle" rowspan="1" colspan="1">&gt;100</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<bold>4</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">(56.54 &#177; 1.52)</td><td align="center" valign="middle" rowspan="1" colspan="1">(65.92 &#177; 3.52)</td><td align="center" valign="middle" rowspan="1" colspan="1">&gt;100</td><td align="center" valign="middle" rowspan="1" colspan="1">&gt;100</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cisplatin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(13.98 &#177; 2.02)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(37.03 &#177; 5.11)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(11.54 &#177; 1.19)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(29.09 &#177; 0.78)</td></tr></tbody></table></table-wrap></floats-group></article></pmc-articleset>